scientific programme 30 april - 3 may 2014 -...
TRANSCRIPT
Adding pieces to the puzzle of endometriosis
Scientific Programme
30 April - 3 May 2014
16.00 to 18.30Contents
Sponsors
Welcome
Partner organisations
WES and committees
Venue plan
At a glance programme
Pre-congress courses Wednesday
Opening ceremony
Programme Thursday
Programme Friday
Programme Saturday
Closing ceremony
Exhibitor / poster floor plan
Sponsor profiles
List of presenters
Local information
4
5
8
9
10
12
14
19
20
24
28
31
32
33
36
42
The organisers of WCE2014 would like to thank our generous sponsors
Diamond
Gold
Ruby
Silver
Bronze
Supported by
4
Dear Colleagues and Friends,
Welcome to São Paulo and to the 12th World Congress on Endometriosis.
The theme of WCE2014, “Adding pieces to the puzzle of endometriosis”, has been chosen because we
are currently experiencing a rapid advancement of new technologies for the diagnosis and management
of endometriosis and, with that, improvements in our understanding of the disease.
At the heart of every congress is the scientific programme, which keeps the momentum of our advancements in endometriosis
alive through a robust exchange of ideas among the experts and learners in the field. We have received more than 500 outstanding
abstracts from the international community, and have put together an extensive and in-depth programme featuring more than 150
speakers and close to 300 poster presentations spanning almost every topic you can imagine that has relevance to endometriosis.
This is truly the world event on endometriosis and I welcome each and every one of you to São Paulo to be part of this clinical and
scientific extravaganza!
For me it is an exciting time to welcome you to São Paulo, one of the top international capitals for gastronomy, architecture and design,
cultural heritage and music. You will find São Paulo home to remarkable museums and concert halls, memorable restaurants, and unique
bars. Do explore the neighborhoods where you will come upon noteworthy cafes, boutiques, and vibrant streets. As the capital of a state
that generates almost half of the Brazilian economy, São Paulo has many reasons for being the first tourist destination in this country.
The Local Organising Committee hopes that you will find time to explore the many cultural opportunities the city has to offer, in between
adding the necessary puzzles to the jigsaw that is endometriosis, so that collectively we can keep the momentum going and continue to
move our field forward for the benefit of millions of women around the world.
Enjoy the Congress and our lively city!
Mauricio Abrao
WCE2014 President
Welcome
5
Maurício Simões Abrão, WCE2014 President
Welcome
SÃO PAULO 2014: ENDOMETRIOSIS BETWEEN SCIENCE AND PASSION
Welcome to the first attendee-centered meeting on endometriosis. In this era of patient-centered medicine,
when the preferences of our patients are crucial for medical decision-making, we thought it was opportune
to adopt a similar approach for the World Congress on Endometriosis, including the topics that matter to
you. This is why the scientific programme has been shaped respecting the results of an online survey in
which you expressed your preferences regarding the issues to be addressed. Moreover, in a scientific
environment characterised by an overwhelming amount of industry-sponsored studies, we continue to foster independent research.
Since 2005 in Maastricht, the vast majority of presentations for our trienniel meeting are selected from the abstracts that you submitted.
On this occasion, we will commemorate Maurice Bruhat, one of the greatest pioneers of modern gynaecology, who left us a few
weeks ago. It was Bruhat who organised the first World Congress on Endometriosis in 1986 in Clermont-Ferrand. We are all
indebted to him, and Michel Canis will dedicate a tribute to this visionary clinician and scientist.
This year we have the special honor of hosting Fiona Godlee, the Editor-in-Chief of the British Medical Journal, who will present
a lecture on overdiagnosis and overtreatment. The Scientific Committee felt that the introduction of a general medical topic of such
importance would benefit also those interested in our specific research area. It is a unique opportunity for us, and you will certainly
appreciate her enlightening thoughts.
Indeed, the paradigms of medicine apply also to the research and management of endometriosis. In 1894 the University of Vienna
commissioned three paintings from Gustav Klimt to celebrate the faculties of Philosophy, Medicine, and Law, reflecting the general theme
of “the triumph of light over darkness”. Medicine was completed in 1901 and provoked a big scandal, as the painting reaffirms that the
connection between life and death is inevitable. Drifting bodies of men and women of different ages, a pregnant woman, a child, are
shown to symbolise the course and flow of life. A skeleton is also featured, to emphasise the antithesis of life, the failure of health.
On the right side of the canvas a floating body of a naked young woman is represented. She appears unconscious, helpless,
beyond the connections with reality and the rest of humanity.
“At the forefront of the canvas stands Hygeia, beautiful and ignorant of the despairing
humanity; she has the power of healing but she keeps it to herself – it is what keeps her
apart from the rest; without her gift, she would be one of them; she guards it like a priestess
guards an oracle; she holds the knowledge of life and death and the antidote to pain but
she does not offer it to the people” The painting has been interpreted as an attack to
physicians, at whose mercy is all of humanity. “Klimt seems to be presenting them as
sorcerers rather than scientists; medicine is but a spell incapable of salvation. People
are born to die – what can medicine promise to break that cycle?”
(http://suitesculturelles.wordpress.com/2011/08/24/vienna-secession-klimt-freud-and-jung/).
6
Paulo Vercellini, President World Endometriosis Society
Welcome
7
Paulo Vercellini President World Endometriosis Society
In 1899 Gustav Klimt painted another masterpiece that seems relevant to our meeting, “Nuda Veritas”.
A naked young woman shows herself hiding nothing but without provocative postures. She is pale, with
red hair, a petrified look, disquieting. The woman holds a mirror facing the viewer. The woman embodies
“The Truth”, undermined by lies, symbolised by the snake at her feet. Facing the mirror toward us, she
admonishes us to avoid mendacity and deception and to search for the truth, whatever risks, efforts, and
troubles this might take.
We are here in São Paulo to accept the challenge that Gustav Klimt directed to physicians with his
Medicine more than a century ago. We are here to reaffirm that our patients are central to our thinking
and acting, and that everything we do is done in their interest, not in our interest. We do not always have
the power of healing, but we convene, in this meeting, to look for the best available modalities to relieve
suffering. And we will always strive in the search of truth. The woman depicted in Nuda Veritas has the
typical phenotypic traits of a patient with endometriosis: pale, sun-sensitive skin, red hair, low body-mass
index. She severely asks for truth: let us confront with an open mind and free thinking, and let us look in
her mirror without fear. The 12th World Congress on Endometriosis can begin.
Paulo Vercellini, President World Endometriosis Society
Partner organisations
WCE2014 acknowledges the support of the following organisations in support and promotion of this congress.
Romanian
Society of Obstetrics and
Gynecology
8
WES and committees
9
World Endometriosis Society
The world congresses on endometriosis extend back to 1986, when Professor Maurice
Bruhat gathered clinicians and scientists, who had a specific interest in endometriosis, for
what became the 1st World Congress on Endometriosis held in Clermont-Ferrand, France.
More than a decade later, at the 6th World Congress on Endometriosis in Quebec in 1998,
Rodolphe Maheux and Jacques Donnez founded the World Endometriosis Society (WES).
As a non-profit organisation, WES promotes and facilitates the exchange of clinical and
scientific experience, thought, and investigation. WES has succeeded in meeting these
goals by:
• gathering thousands of experts at our world congresses for “downright good
discussions” at global meetings to add pieces to the puzzle that is endometriosis;
• supporting two workshops where researchers have brainstormed on research
priorities in endometriosis, resulting in two publications and the acknowledgment
of endometriosis as a research priority (the third workshop is on 4 May 2014!);
• developing the first film on “Endometriosis: symptoms, treatment, and diagnosis”
in five languages;
• organising the first global consensus in the current management of endometriosis
(published in Human Reproduction in 2013);
• continuously publishing opinions and news via our eJournal – sparking that
all important exchange of experience;
• participating in numerous national and regional meetings on endometriosis;
• supporting and contributing to the World Endometriosis Research Foundation
(WERF) in its mission to provide a global platform for researchers to collaborate
on its quest to determine the phenotype of endometriosis and consequently develop
targeted treatments.
Local Organising Committee
WCE2014 President
Mauricio Simoes ABRÃO
WCE2014 Vice President
Carlos Alberto PETTA
Scientific Programme Chair
Rui Alberto FERRIANI
Treasurer
Sergio PODGAEC
Secretary
Eduardo SCHOR
1st Secretary
Claudio CRISPI
Pre-congress Programme Chair
Luis Flavio FERNANDES
Social Programme Chair
Nicolau D’AMICO
International Scientific Committee
Hilary CRITCHLEY, United Kingdom
Johannes EVERS, The Netherlands
Emilio FERNANDEZ, Chile
Linda GIUDICE, USA
Sun-Wei GUO, China
Bernard HÉDON, France
Lone HUMMELSHOJ, United Kingdom
Neil JOHNSON, New Zealand
Ludwig KIESEL, Germany
Alan LAM, Australia
Joao Sabino Cunha NETO, Brazil
Marco Aurelio PINHO DE OLIVEIRA, Brazil
Paulo Ayroza Galvão RIBEIRO, Brazil
Rishma PAI, India
Edgardo ROLLA, Argentina
Luk ROMBAUTS, Australia
Kathy SHARPE-TIMMS, USA
Robert TAYLOR, USA
Paolo VERCELLINI, Italy
Venue plan
10
endometriosis.orgglobal forum for news and information
Endometriosis.org is the global platform linking all stake
holders in endometriosis − one of the most common causes of
pelvic pain and infertility in women.
We facilitate collaboration and information sharing between
women with endometriosis, physicians, scientists, and others
interested in the disease. �is international cooperation and
exchange of experience enables us to deliver up to date,
evidence based, information and news about endometriosis.
Our goal is to empower women with endometriosis to
participate fully in making informed decisions about their
treatment options.
monthly news · updates in research advancements · treatment options · guidelines · coping articles
clinical trials · global support groups · bookstore · congress schedule · www.endometriosis.org
Prog
ram
me
at a
gla
nce
18.3
0 –
19.0
0
19.0
0 –
21.3
0
07.0
0 –
07.5
5
08.0
0 –
10.0
0
10.0
0 –
10.3
0
10.3
0 –
11.0
0
11.0
0 –
11.3
0
11.3
0 –
12.0
0
12.0
0 –
13.3
0
08.0
0 –
17.0
0
Lapa
rosc
opic
sur
gery
in d
ifficu
lt ci
rcum
stan
ces:
tips
and
tric
ksBr
eakf
ast s
ympo
sium
spo
nsor
ed b
y Co
vidie
n
Keyn
ote
lect
ure
#1Re
trog
rade
men
stru
atio
n, ir
on, a
nd o
xida
tive
stre
ss
Keyn
ote
lect
ure
#2Pe
riton
eal l
esio
ns: a
real
dis
ease
?
Keyn
ote
lect
ure
#3M
ater
nal p
regn
ancy
hor
mon
es a
nd e
ndom
etrio
sis
Keyn
ote
lect
ure
#4Th
e pa
tient
’s ro
le in
med
ical
dec
isio
n m
akin
g
Futu
re p
ersp
ectiv
es o
n th
e di
agno
sis
and
trea
tmen
t of e
ndom
etrio
sis
11.4
5 –
13.1
5 Lu
nch
sym
posi
um s
uppo
rted
by A
bbVi
eTh
e im
port
ance
of a
men
orrh
ea
in th
e m
anag
emen
t of e
ndom
etrio
sis
12.1
5 –
13.1
5 Lu
nch
sym
posi
um s
pons
ored
by
LIBB
S
Endo
met
riosi
s m
anag
emen
t: in
divi
dual
isat
ion
and
the
role
of
Allu
eren
e®/V
isan
ne®
(die
noge
st, 2
mg)
11.4
5 –
13.1
5 Lu
nch
sym
posi
um s
pons
ored
by
Baye
r Hea
lthca
re
Vide
o se
ssio
n#2
Se
ssio
n #1
0Ge
netic
sSe
ssio
n #9
Epid
emio
logy
Sess
ion
#8En
dom
etriu
m
Inno
vatio
n in
end
omet
riosi
s: p
ersp
ectiv
es fr
omac
adem
ia a
nd in
dust
ryBr
eakf
ast s
ympo
sium
spo
nsor
ed b
y Ba
yer H
ealth
care
Mai
n se
min
ar #
1Ge
netic
s, e
pige
netic
s,
and
here
dita
ry a
spec
ts
Mai
n se
min
ar #
5M
echa
nism
s of
pai
nM
ain
sem
inar
#9
Endo
met
riosi
s an
d ca
ncer
Mai
n se
min
ar #
2Ad
enom
yosi
sM
ain
sem
inar
#6
New
dru
gsM
ain
sem
inar
#10
Prev
entio
n an
d m
anag
emen
t of
recu
rren
ces
Wed
nesd
ay 3
0 Ap
ril 2
014
Pre-
cong
ress
cou
rses
Wor
ld E
ndom
etrio
sis
Soci
ety
Gene
ral A
ssem
bly
Open
ing
cere
mon
y fo
llow
ed b
y a
cock
tail
rece
ptio
n
Thur
sday
1 M
ay 2
014
Frid
ay 2
May
201
4Sa
turd
ay 3
May
201
4
Refr
eshm
ents
, pos
ter v
iew
ing
and
exhi
bits
13.3
0 –
14.0
0
14.0
0 –
14.3
0
14.3
0 –
15.0
0
15.0
0 –
15.3
0
15.3
0 –
16.0
0
16.0
0 –
17.3
0
Clos
ing
cere
mon
y an
d aw
ards
Keyn
ote
#5W
ERF
EPHe
ct: G
loba
l har
mon
isat
ion
of re
sear
ch
Keyn
ote
#6De
finiti
ve s
urge
ry: w
hy, w
hen,
and
how
?
Vide
o se
ssio
n #1
Se
ssio
n #7
Qual
ity
of li
fe
Sess
ion
#3Pa
thog
enes
isSe
ssio
n #6
Imm
unol
ogy
an
d
stem
cel
ls
Sess
ion
#2In
fert
ility
/ART
Sess
ion
#5Di
agno
sis
Sess
ion
#1Su
rgic
alth
erap
y
Sess
ion
#4M
edic
alth
erap
y
Thur
sday
1 M
ay 2
014
Frid
ay 2
May
201
4Sa
turd
ay 3
May
201
4
Mai
n se
min
ar #
3Im
mun
olog
y an
d st
em c
ells
Mai
n se
min
ar #
7 N
on-in
vasi
ve d
iagn
osis
17.3
0 –
18.3
0
Mai
n se
min
ar #
8 M
anag
emen
t of p
ain
and
in
fert
ility
in d
eep
dise
ase
Mai
n se
min
ar #
4En
dom
etrio
ma
and
ovar
ian
rese
rve
Post
er s
essi
on w
ith re
fres
hmen
tsPo
ster
ses
sion
with
refr
eshm
ents
13
Re
fres
hmen
ts, p
oste
r vie
win
g an
d ex
hibi
ts
16.00 to 18.30Wednesday 30 April 2014
14
Roberto Blasbalg (BR)
Relevance of imaging exams in the treatment planning of patients with endometriosisMichel Canis (FR)
Protocols: Ultrasound and Magnetic ResonanceLeandro Accardo de Mattos (BR)
Ultrasound and MRI in endometriomas. When suspecting malignancy?Ana Luisa Alencar De Nicola (BR) and Roberto Blasbalg (BR)
DISCUSSION
Coffee break
Vivian Amaral (BR)
Correlation of MRI with surgical findings: intestinal and retrocervical sitesAlice Brandão (BR)
Ultrasound with bowel prepar: intestinal and retrocervical sites Manoel Orlando Gonçalves (BR)
MRI of bladder and ureter: relevance of parametrium Alice Brandão (BR)
DISCUSSION
LUNCH (not included in the price of the course)
Kleber Chagas (BR)
MRI and US of pelvic floor and atypical sites Leandro Accardo de Mattos (BR)
What is the main imaging exam to use for the staging of endometriosis? Eduardo Schor (BR) and Sergio Podgaec (BR)
Ultrasound mapping of pelvic endometriosis: does the location and number of lesions affect the diagnostic accuracy? Tom Holland (UK)
DISCUSSION
Coffee break
Sergio Podgaec
Training and learning curve on specialized protocols Scott Young (US)
MRI and US in tipical and atypical adenomyosis Roberto Blasbalg (BR)
Live ultrasound with questions from the audience Manoel Orlando Gonçalves (BR)
This course is organised by:
Endometriosis anatomy and pathophysiologyIgor Padovesi Mota (BR)
An overview of current medical and surgical interventionsLydia Myung (BR)
Assessing quality of life and psycho-social factors in women with endometriosisJamir Sardá (BR)
DISCUSSION
Pre-operative work-up – how can nurses be involved?Ana Paula Klautau (BR)
The role of physical therapy for post-op and for long-term pain managementSallie Sarrell (US)
Self-help programmesMaria Eugenia Albuquerque (BR)
DISCUSSION
This course is organised by
WCE2014 Pre-congress Course #1:Update on diagnostic imaging of endometriosis
Wednesday 30 April 2014 08.30 – 17.00
CHAIRS | Manoel Orlando Gonçalves(BR), Alice Brandão (BR), and Scott Young (US)
WCE2014 Pre-congress Course #2:The role of nurses and allied health professionals in caring for women with endometriosis
Wednesday 30 April 2014 14.00 – 17.00
CHAIRS | Vibeke Amelung RN (DK) and Mariana Matzenbacker RN (BR)
Coordinator: 14.00 – 14.15
08.30 – 09.0014.15 – 14.30
09.00 – 09.30 14.30 – 15.00
09.30 – 10.00
15.00 – 15.30
10.15 – 10.45
10.00 – 10.15 15.30 – 15.45
Coordinator: 15.30 – 15.45
10.45 – 11.15 16.15 – 16.30
16.30 – 17.00 11.15 – 11.45
11.45 – 12.15
12.15 – 12.30
12.30 – 14.00
Coordinator:
14.00 – 14.20
14.20 -14.40
14.40 – 15.00
15.00 – 15.15
15.15 – 15.40
Coordinator:
15.40 – 16.00
16.00 – 16.20
16.20 – 17.00
BALL ROOM 1
BALL ROOM 4
16.00 to 18.30Wednesday 30 April 2014
15
Role of surgery in the treatment of endometriosisMauricio Abrao (BR)
Retroperitoneal anatomy of female pelvis: what we need to know for a safe surgery for endometriosis?Paulo Ayroza Galvão Ribeiro (BR)
Endometriosis of the anterior compartment: vesical and ureteral endometriosis. Surgical anatomy and laparoscopic approach.Mario Malzoni (IT)
Endometriosis of the posterior compartment: Pouch of Douglas, recto-vaginal septum, utero-sacral ligaments. Surgical anatomy and laparoscopic approach.Jörg Keckstein (AT)
BREAK
Endometriosis of the rectum and lateral compartments: nerve-sparing rectal and parametrial resection for deep infiltrating endometriosis. Surgical anatomy and laparoscopic approach.Marcello Ceccaroni (IT)
Endometriosis of uncommon sites (diaphragm, pericardium, pleura, groin). Surgical anatomy and laparoscopic approachRoberto Clarizia (IT)
Endometriosis of the somatic nerves and pelvic wall. Surgical anatomy and laparoscopic approach. Marcello Ceccaroni (IT)
Q&A and DISCUSSION
Surgical management of ovarian endometriosis and fertility considerations Marco Aurelio Oliveira (BR)
Understanding principles in the use of energy in laparoscopic/robotic excision of endometriosis Armando Romeo (BR)
Avoiding complications through mastery of anatomy Carlo De Cicco (IT)
Q&A and DISCUSSION
LUNCH (not included in the price of the course)
Surgical management of adenomyosis Jörg Keckstein (AT)
New Technology in Surgery: 3D imaging in Laparoscopy Kevin Stepp (US)
Microlaparoscopy for endometriosis treatment Mario Malzoni (IT)
The future of robotic surgery for endometriosis Arnold Advincula (US)
Current use of laser for endometriosis treatment Rosanne Kho (US)
BREAK
Video festival from the faculty
Q&A and DISCUSSION
Pelvic pain and non ovarian endometriosisP Santulli (FR)
Importance and modalities of imaging work-upLF Fernandes (BR)
Non ovarian localizations of endometriosis: symptoms and health impactS Singh (CA)
Which relationship between adenomyosis and deep endometriosis?C Chapron (FR)
COFFEE BREAK
Medical treatments for non ovarian endometriosis: are they specific? F Petraglia (IT)
Surgery for non ovarian endometriosisF Carmona (ES)
Impact of non ovarian endometriosis on infertilityC Petta (BR)
Management of infertility in deep endometriosis A Popov (RU)
This course is organised by
WCE2014 Pre-congress Course #3:Anatomy, energy, and new technologies for the surgical management of endometriosis
Wednesday 30 April 2014 08.30 – 17.00 CHAIRS | Manoel Orlando Gonçalves(BR), Alice Brandão (BR), and Scott Young (US)
WCE2014 Pre-congress Course #4:Non-ovarian endometriosis
Wednesday 30 April 2014 14.00 – 17.00 PRESIDENT | Felice Petraglia (IT)CHAIRS | Carlos Petta (BR) and Charles Chapron (FR)
08.30 – 08.50 14.00 – 14.20
08.50 – 09.10 14.20 – 14.40
08.50 – 09.1014.40 – 15.00
09.10 – 09.30
15.00 – 15.20
15.20 – 15.40
09.50 – 10.10
15.40 – 16.00
10.10 – 10.30 16.00 – 16.20
10.30 – 10.50
16.20 – 16.40
10.50 – 11.10
16.40 – 17.00
11.10 – 11.30
11.30 – 11.50
11.50 – 12.10
12.10 – 12.30
12.30 – 12.45
12.45 – 13.50
13.50 – 14.10
14.10 – 14.30
14.30 – 14.50
14.50 – 15.10
15.10 – 15.30
15.30 – 15.50
15.50 – 16.40
16.40 – 17.00
BALL ROOM 2
BALL ROOM 3
16.00 to 18.30Wednesday 30 April 2014
16
Key mechanisms regulating endometriosis Ludwig Kiesel (DE)
Retroperitoneal anatomy of female pelvis: what we need to know for a safe surgery for endometriosis?Ludwig Kiesel (DE)
Anti-Apoptotic HMGA 2 Protein is a Key Molecule in the Pathogenesis and Development of Endometriosis Wolfgang Kuepker (DE)
Is adenomyosis an indication or contraindication for subtotal hysterectomy? Harald Krentel (DE)
Impact of surgical and hormonal therapy on endometriosisLiselotte Mettler (DE) and Ibrahim Alkatout (DE)
Risk factors for urogenital endometriosisMichel Müller (CH)
COFFEE BREAK
Pre- and postmenopausal factors influencing postmenopausal health Dietmar Haas (CH)
Influence of endometriosis on COH and oocyte quality in an ART cycle Omar Shebl (CH)
Pregnancy specific features in endometriosis Stefan Renner (DE)
Delivery after operation for deep infiltration endometriosis Peter Oppelt (CH)
Cell surface receptors as targets in endometriosis Martin Goette (DE)
DISCUSSION
This course is organised by
Sponsored by
Mild endometriosis and infertility: is there a link? Paula Navarro (BR)
Discussion
Adenomyosis and infertilityVivian Ferreira do Amaral (BR)
Discussion
Advanced endometriosis: Surgery or IVF? Dominique DeZiegler (FR)
Discussion
Appropriate ovarian stimulation for endometriosis patients Joao Antonio Dias Junior (BR)
Discussion
Treatment of poor responders and recurrent implantation failureRui Ferriani (BR)
Discussion
Tips and tricks for IVF laboratory in endometriosisCarlos Alberto Petta (BR)
Discussion
Clinical application of biomarkers of ovarian reserveJoao Sabino Neto (BR)
Discussion
Current status of cryopreservation before treating advanced endometriosis David Adamson (US)
Discussion
WCE2014 Pre-congress Course #5:Light into the myth of endometriosis
Wednesday 30 April 2014 10.30 – 13.30
CHAIRS | Liselotte Mettler (DE) and Ludwig Kiesel (DE) and Sylvia Mechsner (DE)
WCE2014 Pre-congress Course #6:Treatment considerations for infertility and endometriosis
Wednesday 30 April 2014 09.30 – 13.30
CHAIRS | Rui Ferriani (BR) and Carlos Petta (BR) 10.30 – 10.45 09.30 – 09.50
08.50 – 09.10
10.45 – 11.00
09.50 – 10.10
11.00 – 11.1509.10 – 09.30
11.15 – 11.30 10.40 – 11.00
11.30 – 11.45
11.30 – 11.45
11.05 – 11.30
11.30 – 11.50
12.00 – 12.15
11.55 – 12.15 12.30 – 12.45
12.30 – 12.4510.50 – 11.10
12.45 – 13.00 11.10 – 11.30
11.30 – 11.50
11.50 – 12.10
13.00 – 13.15
13.15 – 13.30
BALL ROOM 3
BALL ROOM 4
GY
N 6
3 02
/201
4/A
-E
Better VisionLoop Excision Under Magnification with the VITOM® System
KARL STORZ GmbH & Co. KG, Mittelstraße 8, 78532 Tuttlingen/Germany, Phone: +49 (0)7461 708-0, Fax: +49 (0)7461 708-105, E-Mail: [email protected] KARL STORZ Endoscopy America, Inc, 2151 E. Grand Avenue, El Segundo, CA 90245-5017, USA, Phone: +1 424 218-8100, Fax: +1 800 321-1304, E-Mail: [email protected]
KARL STORZ Endoscopia Latino-America, 815 N. W. 57 Av., Suite No. 480, Miami, FL 33126-2042, USA, Phone: +1 305 262-8980, Fax: +1 305 262-89 86, E-Mail: [email protected] KARL STORZ Endoscopy Canada Ltd., 7171 Millcreek Drive, Mississauga, ON L5N 3R3, Canada, Phone: +1 905 816-4500, Fax: +1 905 858-4599, E-Mail: [email protected]
www.karlstorz.com
GESTINOL 28® Gestodeno 75 mcg + Etinilestradiol 30 mcg contendo uma cartela ou três cartelas com 28 comprimidos revestidos. Uso oral e adulto. Indicações: contracepção contínua. Contraindicações: TVP (trombose venosa profunda), tromboembolismo (TE), doença cerebrovascular (DCV) ou arterial coronariana, fibrilação atrial, valvulopatias trombogênicas, distúrbios trombogênicos, hipertensão não controlada, distúrbios graves da função hepática, doença hepática ativa, história prévia ou atual de tumores hepáticos, diabetes com alterações vasculares, tumores hormônio-dependentes (útero/mama), sangramento vaginal não diagnosticado, tabagismo, gravidez confirmada ou suspeita e hipersensibilidade a qualquer componente do medicamento. Precauções e advertências: hipertrigliceridemia persistente, intolerância à glicose ou diabetes mellitus, depressão, “spotting”. Enxaqueca não habitual, perturbações visuais ou auditivas, tromboflebite, tromboembolia; angina, cirurgias eletivas, imobilização forçada, icterícia, hepatite, prurido generalizado, hipertensão e gravidez. Derrame cerebral ou IM; TE e trombose venosa ou arterial; proptose, diplopia, papiledema, lesões vasculares retinianas; hipertensão arterial, neoplasia cervical intraepitelial, câncer de mamas, neoplasia ou doença hepática, AVC, tabagismo.Gravidez e lactação: Categoria de risco X. Não é recomendado o uso de contraceptivos orais combinados (COC) até que a lactante tenha interrompido a amamentação. Este medicamento não deve ser utilizado por mulheres grávidas ou que possam ficar grávidas durante o tratamento. Interações com medicamentos, alimentos e álcool: fenitoínas, barbitúricos, primidona, carbamazepina, rifampicina, oxcarbazepina, topiramato, felbamato, ritonavir, griseofulvina, produtos contendo hipérico, certos antibióticos (penicilinas e tetraciclinas), atorvastatina, ácido ascórbico, paracetamol, inibidores do citocromo P450 (indinavir, fluconazol e troleandomicina), ciclosporina, teofilina, corticosteroides, lamotrigina, glucocorticoides, flunarizina, anticoagulantes, antidepressivos tricíclicos, diazepam, clorodiazepóxido. Reações Adversas e alterações de exames laboratoriais: cefaleia, enxaqueca e “spotting”; vaginite, candidíase, alterações de humor, depressão, alteração de libido, nervosismo, tontura, náuseas, vômitos, dor abdominal, acne, reações nas mamas, dismenorreia, alteração da secreção e ectrópio cervical, edema, alterações do peso e de apetite. Cólicas abdominais, distensão, erupções cutâneas, cloasma, hipertensão arterial, alterações séricas de lipídeos, hipertrigliceridemia; IC, AVC, TV e embolia pulmonar; neoplasia cervical intraepitelial e câncer cervical, câncer de mama, distúrbios gástricos, alterações da libido. Amenorreia pós-pílula ou oligomenorreia; fechamento da epífise em adolescentes. Posologia: iniciar no 1º dia da menstruação. Um comprimido ao dia, sempre no mesmo horário. Iniciar a cartela seguinte após o término da anterior e manter o tratamento de forma ininterrupta, e a pausa a critério médico. Usando pela primeira vez: iniciar a tomada no 1° dia do ciclo natural. No lugar de outro contraceptivo oral: tomar GESTINOL 28® de preferência no dia seguinte ao último comprimido ativo do COC anterior ter sido ingerido ou, no máximo, no dia seguinte ao intervalo habitual sem comprimido ou com comprimido inerte do COC anterior. No lugar de outro método com apenas progestagênio: pode parar a minipílula em qualquer dia e começar GESTINOL 28® no dia seguinte. Tomar GESTINOL 28® no dia da remoção do implante ou, no caso de utilização de contraceptivo injetável, esperar o dia programado para a próxima injeção. Em todas essas situações, a paciente deve utilizar outro método não hormonal de contracepção durante os sete primeiros dias de administração dos comprimidos. Após aborto no primeiro trimestre: pode tomar GESTINOL 28® imediatamente, não são necessários outros métodos contraceptivos. Após parto ou aborto no segundo trimestre: o tratamento com COCs deve começar 3-6 semanas após o parto em mães não lactantes ou após aborto no segundo trimestre. A paciente deve utilizar método não hormonal de contracepção durante os sete primeiros dias de administração dos comprimidos. Esquecimento: se menor que 12 horas, tomar GESTINOL 28® assim que se lembrar e o restante dos comprimidos no horário habitual. Maior que 12 horas ou mais, tomar o comprimido esquecido tão logo se lembre, mesmo que isso signifique tomar dois comprimidos num único dia e os comprimidos seguintes no horário habitual. Usar métodos contraceptivos de barreira por sete dias. Na ocorrência de vômitos ou diarreia dentro de 3-4 horas após a ingestão de GESTINOL 28®, continuar o tratamento para evitar sangramento prematuro de privação e usar método contraceptivo não hormonal até o final do ciclo. Reg. MS 1.0033.0027/Farm. resp: Cintia Delphino de Andrade - CRF-SP nº 25.125. LIBBS FARMACÊUTICA LTDA/CNPJ 61.230.314/0001-75/Rua Alberto Correia Francfort, 88/Embu das Artes-SP/Indústria brasileira/GESTINOL-MB01-12/Serviço de Atendimento Libbs: 08000-135044. VENDA SOB PRESCRIÇÃO MÉDICA. A persistirem os sintomas, o médico deve ser consultado. Documentação científica e informações adicionais estão à disposição da classe médica, mediante solicitação.
Contraindicação: trombose venosa profundaInterações medicamentosas: antibióticos (penicilina e tetraciclina)
Referência Bibliográfica: 1. GESTINOL 28®. São Paulo: Libbs Farmacêutica Ltda. Bula do medicamento.
EXISTEM DUAS MANEIRAS DE PROTEGERO QUE AS SUAS PAC IENTES TÊM DE MAIS PREC IOSO:
ISOLANDO, ESCONDENDO E APAGANDO SEU BRILHO.
OU ASSOCIANDO EFICÁCIA1 COM A FEMINILIDADE DA MULHER.
C
M
Y
CM
MY
CY
CMY
K
Anuncio_Sonicision_21x14cm.pdf 1 3/7/14 12:57 PM
Opening ceremony
CHAIRS | Mauricio Abrao (BR) and Paolo Vercellini (IT)
19.00
19.05
19.25
20.00
Welcome to the 12th World Congress on Endometriosis Paolo Vercellini (IT)
KEY NOTE: Over-diagnosis, over-treatment, and responsible management of finite healthcare resources Fiona Godlee (UK)
Welcome reception
Welcome to Sao Paulo and WCE2014 Mauricio Abrao (BR)
Maurice Bruhat in memoriam Michel Canis (FR)
19.15
Sponsored by 19
17 Thur
sday
1 M
ay 2
014
07.
00 -
15.
30
07.0
0 –
07.5
5
08.0
0 –
08.2
0
08.2
0 –
08.3
5
08.3
5 –
08.5
0
08.5
0 –
09.0
5
09.0
5 –
09.2
0
09.2
0 –
09.3
5
09.3
5 –
10.0
0
10.0
0 –
10.3
0
10.3
0 –
11.0
0
B1-1
Cha
lleng
es o
f the
retr
oper
itone
um: t
echn
ique
s of
dis
sect
ion
and
hem
osta
sis
Au
drey
Tsu
nada
B1-2
Sur
gery
str
ateg
ies
in la
rge
uter
us a
nd fr
ozen
pel
vis
Paul
o Ay
roza
Gal
vão
Ribe
iro
Lapr
asco
pic
surg
ery
in d
ifficu
lt ci
rcum
stan
ces:
tips
and
tric
ksCh
air |
Pau
lo A
yroz
a Ga
lvão
Ribe
iro
Refr
eshm
ents
, pos
ter v
iew
ing
and
exhi
bits
Gene
tics,
epi
gene
tics,
and
her
edita
ry a
spec
tsCh
airs
| Kr
ina
Zond
erva
n (U
K) a
nd M
arco
Aur
elio
Pin
ho d
e Ol
iveira
(BR)
M1-
0 Ge
netic
s, e
pige
netic
s, a
nd h
ered
itary
asp
ects
Gra
nt M
ontg
omer
y (A
U)
Keyn
ote
lect
ure
1
Chai
rs |
Kath
y Ti
mm
s (U
S) a
nd E
dgar
do S
chor
(BR)
Retr
ogra
de m
enst
ruat
ion,
iron
, and
oxi
dativ
e st
ress
Lu
iz Fe
rnan
do P
ina
de C
arva
lho
(BR)
Aden
omyo
sis
Chai
rs |
Jörg
Kec
kste
in (A
T) a
nd L
uiz A
uge
(AR)
M
2-0
Ad
enom
yosi
s Fr
anci
sco
Carm
ona
(ES)
M1-
1 La
rge-
scal
e ex
ome
chip
gen
otyp
ing
reve
als
nove
l cod
ing
varia
tion
asso
ciat
ed
with
end
omet
riosi
s
Andr
ew M
orris
(UK)
M1-
4
Geno
mic
rear
rang
emen
ts (c
opy
num
ber v
aria
nts)
may
pla
y a
role
in th
e
path
ogen
esis
of e
ndom
etrio
sis
Ha
ns A
lber
tsen
(US)
M2-
2
Radi
ofre
quen
cy th
erm
al a
blat
ion
for s
ympt
omat
ic u
terin
e fo
cal a
deno
myo
sis
-
pros
pect
ive
prel
imin
ary
expe
rienc
eCo
lette
Cam
pana
(IT)
M1-
5
A se
arch
for s
omat
ic m
utat
ions
in d
eep
infil
trat
ing
endo
met
riosi
s
usin
g ex
ome
sequ
enci
ng
Met
te N
yega
ard
(DK)
M2-
4
Lapa
rosc
opic
radi
ofre
quen
cy th
erm
al a
blat
ion:
A n
ew a
ppro
ach
to s
ympt
omat
ic
uter
ine
foca
l ade
nom
yosi
s
Robe
rto C
lariz
ia (I
T)
M2-
5
The
effic
ienc
y of
intr
a-va
gina
l dan
azol
sup
posi
tory
ther
apy
for i
nfer
tile
wom
en w
ith a
deno
myo
sis
Ka
nako
Mat
sum
oto
(JP)
Ques
tions
, ans
wer
s an
d di
scus
sion
s on
futu
re re
sear
ch p
riorit
ies
Gran
t Mon
tgom
ery
(AU)
Ques
tions
, ans
wer
s an
d di
scus
sion
s on
futu
re re
sear
ch p
riorit
ies
Fran
cisc
o Ca
rmon
a (E
S)
M2-
3
Invo
lvem
ent o
f HGF
-indu
ced
epith
elia
l-mes
ench
ymal
tran
sitio
n in
ade
nom
yosi
s
Khal
eque
Kha
n (J
P)
M1-
2
Met
a-an
alys
is o
f GW
AS s
igna
ls fo
r end
omet
riosi
s to
dat
e, c
onsi
sten
cy
and
hete
roge
neity
acr
oss
eigh
t dat
aset
s to
talli
ng m
ore
than
11,
000
case
s
and
32,0
00 c
ontr
ols
Ni
lufe
r Rah
mio
glu
(UK)
M1-
3
The
prev
alen
ce a
nd h
erita
bilit
y of
end
omet
riosi
s am
ong
28 8
25 S
wed
ish
twin
s
Ram
a Sa
ha (S
E)
M2-
1
Pale
cel
ls d
iape
desi
s in
the
endo
met
rial-m
yom
etria
l jun
ctio
n zo
ne.
New
insi
ght o
n ad
enom
yosi
s pa
thog
ensi
s
Moh
amed
Ibra
him
(DE)
Spon
sore
d by
Spon
sore
d by
A lig
ht b
reak
fast
buffe
t will
be s
erve
d
GOLD
EN
HALL
BALL
RO
OM
BALL
RO
OM
GOLD
EN
HALL
Imm
unol
ogy
and
stem
cel
ls
Chai
rs |
Yuta
ka O
suga
(JP)
and
Sun
-Wei
Guo
(CN)
M3-
0
Imm
unol
ogy
and
stem
cel
ls
Hugh
Tay
lor (
US)
Endo
met
riosi
s m
anag
emen
t: in
divi
dual
izat
ion
and
the
role
of A
llure
ne®
/Vis
anne
®*
(die
noge
st, 2
mg)
Endo
met
riom
a an
d ov
aria
n re
serv
eCh
airs
| Ch
arle
s M
iller (
US) a
nd R
ui F
erria
ni (B
R)M
4-0
En
dom
etrio
ma
and
ovar
ian
rese
rve
Ed
gard
o So
mig
liana
(IT)
M3-
1
Solu
ble
MIC
A (M
ajor
his
toco
mpa
tibili
ty c
lass
I-re
late
d ch
ain
A): A
pos
sibl
e in
volv
emen
t in
the
path
ogen
esis
of e
ndom
etrio
sis
M
aria
Luc
ia C
arne
vale
Mar
in (B
R)
M3-
4No
tch
inhi
bitio
n re
duce
s st
emne
ss v
ia a
ltere
d ex
pres
sion
of S
OX2,
LIF
R, a
nd P
ODXL
in
an
endo
met
riotic
cel
l lin
e M
artin
Göt
te (D
E)
M4-
2Hy
drod
isse
ctio
n w
ith d
ilute
d pi
tuitr
in fo
r lap
aros
copi
c cy
stec
tom
y of
ova
rian
en
dom
etrio
ma:
A te
chni
que
to re
duce
dam
age
to o
varia
n re
serv
eBi
ng X
u (C
N)
M3-
5Re
peat
ed o
bser
vatio
n of
an
asso
ciat
ion
betw
een
elev
ated
per
itone
al in
flam
mat
ory
cy
toki
nes
and
seve
re d
ysm
enor
rhea
am
ong
wom
en w
ith e
ndom
etrio
sis
Lind
a Gr
iffith
(US)
M4-
4Re
curr
ence
of o
varia
n en
dom
etrio
ma
afte
r lap
aros
copi
c ex
cisi
onAn
a M
aria
Per
eira
(BR)
M4-
5 Pr
imor
dial
folli
cle
loss
afte
r end
omet
riom
a ca
psul
e st
rippi
ng in
lapa
rosc
opic
sur
gery
Rafa
ella
Pet
racc
o (B
R)
Ques
tions
, ans
wer
s an
d di
scus
sion
s on
futu
re re
sear
ch p
riorit
ies
Hugh
Tay
lor (
US)
Ques
tions
, ans
wer
s an
d di
scus
sion
s on
futu
re re
sear
ch p
riorit
ies
Edga
rdo
Som
iglia
na (I
T)
M4-
3Va
riatio
n of
AM
H le
vel f
ollo
win
g en
dom
etrio
ma
abla
tion
usin
g pl
asm
a en
ergy
Horra
ce R
oman
(FR)
M3-
2Re
trog
rade
men
stru
atio
n of
end
omet
rial s
tem
/pro
geni
tor c
ells
in w
omen
w
ith e
ndom
etrio
sis
Caro
line
Garg
ett (
AU)
M3-
3Dy
sfun
ctio
nal u
terin
e na
tura
l kill
er (U
NK) c
ell d
evel
opm
ent i
n en
dom
etrio
sis
Uma
Thiru
chel
vam
(IE)
M4-
1Iro
n av
aila
bilit
y is
incr
ease
d in
indi
vidu
al h
uman
ova
rian
folli
cles
in c
lose
pro
xim
ity
to a
n en
dom
etrio
ma
Pa
ola
Pani
na (I
T)
Keyn
ote
lect
ure
2 Ch
airs
| Ed
mun
d Ba
raca
t (BR
) and
Rob
Tay
lor (
US)
Perit
onea
l les
ions
: a re
al d
isea
se?
Fern
ando
Rei
s (B
R)
11.4
5 -
11.5
0
11.0
0 -
11.3
0
13.3
0 -
13.5
0
13.5
0 -
14.0
5
14.0
5 -
14.2
0
14.2
0 -
14.3
5
14.3
5 -
14.5
0
14.5
0 -
13.0
5
13.0
5 -
15.3
0
11.5
0 -
12.0
5
12.0
5 -
12.2
0
12.2
0 -
12.4
0
12.4
0 -
13.0
0
13.0
0 -
13.3
0
13.1
0 -
13.1
5
GOLD
EN
HALL
BALL
RO
OM
GOLD
EN
HALL
L1-1
Intr
oduc
tion
A
leks
andr
Pop
ov (R
U)
L1-2
Clin
ical
app
licat
ion
of g
enet
ic fi
ndin
gs in
end
omet
riosi
s
Krin
a Zo
nder
van
(UK)
L1-3
End
omet
riosi
s: T
he in
flam
mat
ory
dise
ase
C
harle
s Ch
apro
n (F
R)
L1-4
The
fals
e di
chot
omy
of s
urge
ry a
nd m
edic
al m
anag
emen
t
Mic
hael
Mue
ller (
CH)
L1-5
Evi
denc
e-ba
sed
man
agem
ent o
f end
omet
riosi
s w
ith A
llure
ne®
/Vis
anne
®
Son
y Si
ngh
(CA)
*Visa
nne®
is th
e int
erna
tiona
l com
mer
cial n
ame
for A
llure
ne®
L1-6
Sum
mar
y an
d cl
ose
Car
los
Petta
(BR)
Ques
tions
and
ans
wer
s
A lig
ht lu
nch
will b
e se
rved
Spon
sore
d by
Chai
rs |
Carlo
s Pe
tta (B
R) a
nd A
lexa
ndr P
opov
(RU)
21
19 Thur
sday
1 M
ay 2
014
15.
30 -
18.
30
16.0
0 –
16.1
2
16.1
2 –
16.2
4
16.2
4 –
16.3
6
16.3
6 –
16.4
8
Surg
ical
The
rapy
Chai
rs |
Sony
Sin
gh (C
A) a
nd A
lan
Lam
(AU)
Infe
rtili
ty a
nd A
RTCh
airs
| Ed
gard
o Ro
lla (A
R) a
nd N
icol
au D
’Am
ico
(BR)
Path
ogen
esis
/ ae
tiolo
gyCh
airs
| Asg
i Faz
leaba
s (U
S) a
nd M
oham
ed B
edaiw
y (CA
)Vi
deo
Sess
ion
1Ch
airs
| Pe
ter M
aher
(AU)
and
Lis
elot
te M
ettle
r (DE
)
S1-2
Early
rise
in s
erum
C-r
eact
ive
prot
ein
indi
cate
s su
bseq
uent
sur
gica
l com
plic
atio
n af
ter l
ow a
nter
ior r
esec
tion
for r
ecto
-sig
moi
d en
dom
etrio
sis
Mad
s Ri
iskj
ear (
DE)
S1-1
Co
lore
ctal
rese
ctio
n ve
rsus
rect
al
cons
erva
tive
surg
ery
in th
e m
anag
emen
t of
rect
al e
ndom
etrio
sis:
pre
limin
ary
resu
lts
of E
NDOR
E ra
ndom
ized
tria
l
Hora
ce R
oman
(FR)
S2-1
In
vitr
o fe
rtili
satio
n (IV
F)
embr
yo im
plan
tatio
n is
not
impa
ired
by
end
omet
riosi
s
Jean
Luc
Pou
ly (F
R)
S1-3
Surg
ical
man
agem
ent o
f end
omet
riom
as
on in
vitr
o fe
rtili
zatio
n ou
tcom
es:
A sy
stem
atic
revi
ew a
nd m
eta-
anal
ysis
Clar
a W
u (C
A)
S1-4
Nerv
e-sp
arin
g la
paro
scop
ic e
radi
catio
n
of d
eep
endo
met
riosi
s w
ith s
egm
enta
l re
ctal
and
par
amet
rial r
esec
tion:
Th
e ne
gar m
etho
d. A
pro
spec
tive
Mar
cello
Cec
caro
ni (I
T)
S2-2
Effe
ct o
f ind
uced
per
itone
al
endo
met
riosi
s on
ooc
yte
and
embr
yo
qual
ity in
a m
ouse
mod
el
Jona
than
Coh
en (F
R)
S2-3
Exte
rnal
val
idat
ion
of th
e en
dom
etrio
sis
fe
rtili
ty in
dex
in a
Fre
nch
popu
latio
n.
Tow
ards
indi
vidu
aliz
ed m
anag
emen
t of
infe
rtile
end
omet
riotic
not
yet
acc
epte
d
Jere
my
Bouj
enah
(FR)
S2-4
The
IVF-
lube
tria
l: Li
piod
ol u
terin
e
bath
ing
effe
ct fo
r enh
anci
ng th
e
resu
lts o
f in
vitr
o fe
rtili
satio
n, a
pilo
t ra
ndom
ised
tria
l
Neil
John
son
(NZ)
S3-2
Feta
l and
pos
tnat
al d
evel
opm
enta
l an
omal
ies
afte
r exp
osur
e to
end
omet
riosi
s
in u
tero
affe
ctin
g tw
o ge
nera
tions
not
ye
t acc
epte
d
Kath
y Sh
arpe
-Tim
ms
(US)
S3-3
Met
abol
ic re
prog
ram
min
g of
the
perit
onea
l m
esot
heliu
m b
y TG
F –
may
pro
mot
e
endo
met
riosi
s le
sion
dev
elop
men
t
Vick
y Ja
ne Y
oung
(UK)
S3-4
Loca
lizat
ion
of c
ellu
lar i
nter
actio
ns a
nd
neur
oang
ioge
nesi
s in
dee
ply
inva
sive
en
dom
etrio
sis
impl
icat
es im
port
ant r
ole
of
mac
roph
age
infil
trat
ion
Anto
nia
Fran
cisc
o (B
R)
V1-2
La
pras
copi
c E/
O ul
tral
ow re
ctal
, bla
dder
, pe
lvic
end
omet
riosi
s
Taha
ni A
lmot
rafi
(AU)
V1-3
Re
stric
tion
of e
ndom
etrio
sis
of th
e le
ft
late
ral i
nfra
ure
teric
and
sup
ra u
rete
ric
para
met
rium
Jenn
ifer U
zan
(FR)
V1-4
Ro
botic
ade
nom
yom
etct
omy
to p
rese
rve
th
e ut
erus
for f
utur
e pr
egna
ncy
Sa
ng H
oon
Kwon
(KR)
GOLD
EN
HALL
BALL
RO
OM 4
BALL
RO
OM 1
BALL
RO
OM 2
-3
Refr
eshm
ents
, pos
ter v
iew
ing
and
exhi
bits
15.3
0 -
16.0
0
S3-1
In
tra-
tissu
e es
trad
iol,
prog
este
rone
an
d te
stos
tero
ne c
once
ntra
tions
in
endo
met
riosi
s ar
e im
bala
nced
by
loca
l st
eroi
d m
etab
olis
m n
ot y
et a
ccep
ted
Kais
a Hu
htin
en (F
I)
V1-1
Su
rgic
al tr
eatm
ent o
f mul
tiple
site
s bo
wel
en
dom
etrio
sis
– ho
w w
e pe
rfor
m
Patri
ck B
elle
lis (B
R)
16.4
8 –
17.0
0
17.0
0 –
17.1
2
17.1
2 –
17.2
4
17.2
4 –
17.3
0
17.3
0 –
18.3
0
S1-5
Part
ial r
esec
tion
of th
e ex
tras
eros
al
pelv
ic fa
scia
is a
cru
cial
sur
gica
l ste
p
in th
e m
anag
emen
t of p
atie
nts
with
co
lore
ctal
end
omet
riosi
s M
arco
s Ba
llest
er (F
R)
S2-5
Mat
erna
l per
itone
al fl
uid
sphi
ngol
ipid
s
in e
ndom
etrio
sis-
asso
ciat
ed in
fert
ility
Yi
e Ho
u Le
e (S
G)
S3-5
Endo
met
riosi
s an
d hi
gh ri
sk
of c
omor
bidi
ties:
Ana
lysi
s of
mor
e
than
hal
f mill
ion
patie
nts
Luiz
Fern
ando
Pin
a Ca
rval
ho (B
R)
V1-5
Bo
wel
end
omet
riosi
s –
Robo
tic tr
eatm
ent
with
dis
coid
rese
ctio
n –
the
tech
niqu
e Du
arte
Rib
eiro
(BR)
S1-6
Lapa
rosc
opic
man
agem
ent o
f dee
ply
in
filtr
atin
g en
dom
etrio
sis:
A c
ohor
t pr
ospe
ctiv
e st
udy
with
10-
year
follo
w u
p Ji
nhua
Len
g (C
N)
S1-7
Lapa
rosc
opic
neu
rolis
ys fo
r dee
p
endo
met
riosi
s in
filtr
atin
g pe
lvic
wal
l an
d so
mat
ic n
erve
s: A
retr
ospe
ctiv
e
stud
y on
26
patie
nts
Robe
rto C
lariz
a (IT
)
Disc
ussi
on
S2-6
Patie
nt s
atis
fact
ion
conc
erni
ng a
ssis
ted
repr
oduc
tive
tech
nolo
gy tr
eatm
ent i
n
mod
erat
e to
sev
ere
endo
met
riosi
s
not y
et a
ccep
ted
Lise
tte v
an d
er H
ouw
en (N
L)
S2-7
Perit
onea
l end
omet
riosi
s an
d al
lelic
fr
eque
ncy
of G
DF-9
(rs2
5428
5, rs
2542
86,
rs10
4912
79),
anti-
mul
leria
n ho
rmon
e an
d re
cept
or (A
MHR
2) g
enes
sin
gle
not y
et
acce
pted
Em
ily D
e Co
nto
(BR)
Disc
ussi
on
S3-6
The
endo
cann
abin
oid
syst
em m
odul
ates
en
dom
etrio
sis
deve
lopm
ent i
n a
mou
se
mod
el: I
nves
tigat
ing
the
role
of t
he
CB1
rece
ptor
Paol
a Pa
nina
(IT)
S3-7
Nerv
e fib
er a
nd ly
mph
oid
nodu
le
wer
e ob
serv
ed in
pat
holo
gica
l and
im
mun
ohis
tolo
gica
l ana
lysi
s of
cyn
omol
gus
mon
keys
(Mac
aca
fasc
icul
aris
) with
sp
onta
neou
s en
dom
etrio
sis
not y
et a
ccep
ted
Ayak
o Ni
shim
oto-
Kaki
uchi
(JP)
Disc
ussi
on
V1-6
Ad
vant
age
tech
nica
l ass
ocia
te o
f sha
ve
surg
ery
in th
e en
dom
etrio
sis
infil
trat
ing
segm
enta
l res
ectio
n
Univa
ldo
Saga
e (B
R)
V1-7
Th
ere
is m
ore
to e
ndom
etrio
sis
than
w
e ca
n se
e
Tam
er S
ecki
n (U
S)
Disc
ussi
on
Post
er s
essi
on w
ith re
fres
hmen
ts
GOLD
EN
HALL
BALL
RO
OM 4
BALL
RO
OM 1
BALL
RO
OM 2
-3
Surg
ical
The
rapy
Chai
rs |
Sony
Sin
gh (C
A) a
nd A
lan
Lam
(AU)
Infe
rtili
ty a
nd A
RTCh
airs
| Ed
gard
o Ro
lla (A
R) a
nd N
icol
au D
’Am
ico
(BR)
Path
ogen
esis
/ ae
tiolo
gyCh
airs
| Asg
i Faz
leaba
s (U
S) a
nd M
oham
ed B
edaiw
y (CA
)Vi
deo
Sess
ion
1Ch
airs
| Pe
ter M
aher
(AU)
and
Lis
elot
te M
ettle
r (DE
) 23
Frid
ay 2
May
201
4 0
7.00
- 1
5.30
07.0
0 –
07.0
5
07.0
5 –
07.2
0
07.2
0 –
07.3
5
07.3
5 –
07.5
5
08.0
0 –
08.2
0
08.2
0 –
08.3
5
08.3
5 –
08.5
0
08.5
0 –
09.0
5
09.0
5 –
09.2
0
09.2
0 –
09.3
5
09.3
5 –
10.0
0
10.0
0 –
10.3
0
10.3
0 –
11.0
0
B2-1
Insi
ghts
into
cur
rent
dru
g de
velo
pmen
t at B
ayer
O
liver
Mar
tin F
isch
er (D
E)
B2-2
Bey
ond
horm
onal
sup
pres
sion
: New
ther
apeu
tic a
venu
es in
end
omet
riosi
s re
sear
ch a
t Bay
er
Tho
mas
M. Z
olln
er (D
E)
B2-3
Sen
sitiz
atio
n an
d pa
in m
echa
nism
s in
end
omet
riosi
s
Kat
y Vi
ncen
t (UK
)
Inno
vatio
n in
end
omet
riosi
s: p
ersp
ectiv
es fr
om a
cade
mia
and
indu
stry
Chai
r | C
harle
s Ch
apro
n (F
R)
Refr
eshm
ents
, pos
ter v
iew
ing
and
exhi
bits
Mec
hani
sms
of p
ain
Chai
rs |
Pam
ela
Stra
tton
(US)
and
Mic
hel C
anis
(FR)
M5-
0 M
echa
nism
s of
pai
n Sy
lvia
Mec
hsne
r (DE
)
Keyn
ote
lect
ure
3
Chai
rs |
Joa
o Sa
bina
Cun
ha-F
ilho
(BR)
and
Has
san
Salla
m (E
G)
Mat
erna
l pre
gnan
cy h
orm
ones
and
end
omet
riosi
s
Ivo B
rose
ns (B
E)
New
dru
gsCh
airs
| Fe
lice
Petra
glia
(IT)
and
Car
los
Petta
(BR)
M
6-0
Ne
w d
rugs
Erk
ut A
ttar (
TR)
M5-
1 Es
trog
en re
cept
or s
ubty
pe d
epen
dent
mac
roph
age
activ
atio
n le
ads
to a
sen
sory
ner
ve
outg
row
th in
per
itone
al e
ndom
etrio
sis
Julia
Arn
old
(DE)
M5-
4
Estr
ogen
rece
ptor
sub
type
s m
odul
ate
how
ner
ve fi
bres
influ
ence
blo
od v
esse
ls a
nd
mac
roph
ages
in p
erito
neal
end
omet
riosi
s Er
in G
reav
es (U
K)
M6-
2
Phar
mac
okin
etic
s of
ela
golix
, an
oral
gon
adot
ropi
n-re
leas
ing
horm
one
(GnR
H)
anta
goni
st ta
rget
ed in
the
trea
tmen
t of e
ndom
etrio
sis
and
uter
ine
leio
myo
mas
Ju
ki N
G (U
S)
M5-
5
Do c
linic
al p
ain
mea
sure
s co
rrel
ate
to s
ubco
rtic
al b
rain
vol
ume
in w
omen
w
ith c
hron
ic p
elvi
c pa
in?
Sara
h M
urra
y (U
K)
M6-
4
Inhi
bitio
n of
type
1 1
7ß-h
ydro
xyst
eroi
d-de
hydr
ogen
ase
impa
irs th
e sy
nthe
sis
of
est
roge
ns in
end
omet
riosi
s
Andr
ea R
oman
o (N
L)
M6-
5
Dual
-pro
gest
ogen
-del
iver
y sy
stem
s th
erap
y w
ith le
vono
rges
trel
intr
aute
rine
syst
em a
nd e
tono
gest
rel
subd
erm
al im
plan
t for
refr
acto
ry e
ndom
etrio
sis-
asso
ciat
ed p
elvi
c pa
in: a
n ef
fect
ive
new
ther
apy
Ce
cilia
Ng
(AU)
Ques
tions
, ans
wer
s an
d di
scus
sion
s on
futu
re re
sear
ch p
riorit
ies
Sylvi
a M
echs
ner (
DE)
Ques
tions
, ans
wer
s an
d di
scus
sion
s on
futu
re re
sear
ch p
riorit
ies
Erku
t Atta
r (TR
)
M6-
3
Targ
etin
g y-
box-
bind
ing
prot
ein
1 (Y
B-1)
for t
he tr
eatm
ent o
f end
omet
riosi
s
Cáss
ia G
isel
e Te
rrass
ani S
ilvei
ra (D
E)
M5-
2
Inhi
bitio
n of
PGE
2 re
cept
ors
EP2
and
EP4
decr
ease
s gr
owth
, inn
erva
tion
an
d no
cice
ptio
n of
end
omet
riosi
s Jo
e Ar
osh
(IN)
M5-
3
Nove
l mec
hani
sms
of n
ocic
eptio
n in
ani
mal
and
cel
l mod
els
of e
ndom
etrio
sis
Kr
iste
ena
Ray
(US)
M6-
1
Firs
t pep
tide-
base
d no
n-ho
rmon
al th
erap
y of
end
omet
riosi
s:
Whe
re a
re w
e to
day?
Vi
nay
Sing
h (C
A)
Spon
sore
d by
Spon
sore
d by
A lig
ht b
reak
fast
buffe
t will
be s
erve
d
GOLD
EN
HALL
GOLD
EN
HALL
BALL
RO
OM
BALL
RO
OM
Non-
inva
sive
dia
gnos
is
Chai
rs |
Moa
mar
Al-J
efou
t (JO
) and
Jos
e M
ende
s Al
drig
ht (B
R)M
7-0
No
n-in
vasi
ve d
iagn
osis
Ch
ristia
n Be
cker
(UK)
Futu
re p
ersp
ectiv
es o
n th
e di
agno
sis
and
trea
tmen
t of e
ndom
etrio
sis
Chai
rs |
Arno
ld A
dvin
cula
(US)
and
Ann
emie
k Na
p (N
L)
Man
agem
ent o
f pai
n an
d in
fert
ility
in d
eep
dise
ase
Chai
rs |
Axel
For
man
(DK)
and
Cha
rles
Chap
ron
(FR)
M8-
0
Man
agem
ent o
f pai
n an
d in
fert
ility
in d
eep
dise
ase
Ho
race
Rom
an (F
R)
M7-
1
Ultr
asou
nd m
appi
ng o
f pel
vic
endo
met
riosi
s: d
oes
the
loca
tion
and
num
ber o
f les
ions
af
fect
the
diag
nost
ic a
ccur
acy?
A m
ultic
entr
e di
agno
stic
acc
urac
y st
udy
To
m H
olla
nd (U
K)
M7-
4A
com
bine
d ap
proa
ch o
f ner
ve fi
ber d
etec
tion
plus
infr
ared
spe
ctro
scop
y pr
ofile
in
eut
opic
end
omet
rium
out
perf
orm
s th
e ca
paci
ty o
f eac
h si
ngle
tech
niqu
e to
no
n-in
vasi
vely
dia
gnos
e en
dom
etrio
sis
Raul
Gom
ez (E
S)
M8-
2En
zian
cla
ssifi
catio
n: D
oes
it co
rrel
ate
with
clin
ical
sym
ptom
s am
d th
e as
rm s
core
?Di
etm
ar H
aas
(AT)
M7-
5Hi
gh fi
delit
y fe
nom
ic c
lass
ifier
s to
dia
gnos
e an
d st
age
endo
met
riosi
s Li
nda
Giud
ice
(US)
M8-
4Va
lidat
ing
the
“Eco
syst
em”
for e
ndom
etrio
sis
Bern
ardo
Las
mar
(BR)
M8-
5 An
atom
ophy
siol
ogic
stu
dy o
f pat
ient
s w
ith p
elvi
c en
dom
etrio
sis
inte
stin
al in
volv
emen
tDo
ryan
e M
aria
Doe
Rei
s Li
ma
(BR)
Ques
tions
, ans
wer
s an
d di
scus
sion
s on
futu
re re
sear
ch p
riorit
ies
Chris
tian
Beck
er (U
K)Qu
estio
ns, a
nsw
ers
and
disc
ussi
ons
on fu
ture
rese
arch
prio
ritie
sHo
race
Rom
an (F
R)
M8-
3Ro
botic
-ass
iste
d la
paro
scop
y fo
r dee
p en
dom
etrio
sis:
Inte
rnat
iona
l mul
ticen
tric
retr
ospe
ctiv
e st
udy
Pier
re C
ollin
et (F
R)
M7-
2Ev
alua
tion
of a
n in
nova
tive
mod
el o
f car
e an
d de
dica
ted
serv
ice
for t
eena
gers
and
w
omen
with
per
iod
pain
, pel
vic
pain
and
end
omet
riosi
sM
elis
sa P
arke
r (AU
)
M7-
3Sc
reen
ing
tool
for e
arly
-sta
ge e
ndom
etrio
sis
in p
atie
nts
with
chr
onic
pel
vic
pain
Patri
ck J
r. Ye
ung
(US)
M8-
1Se
vere
ure
tera
l end
omet
riosi
s: p
relim
inar
y re
port
of 3
0 Ca
ses
With
Hyd
rone
phro
sis
Ro
drig
o Fe
rnan
des
(PT)
Keyn
ote
lect
ure
4 Ch
airs
| C
athe
rine
Alla
ire (C
A) a
nd J
uan
Salg
ado
(PR)
The
patie
nt’s
role
in m
edic
al d
ecis
ion
mak
ing
Debo
rah
Bush
(NZ)
Orga
nised
by
Supp
orte
d by
11.4
5 -
12.0
5
11.4
5 -
13.1
5
11.0
0 -
11.3
0
13.3
0 -
13.5
0
13.5
0 -
14.0
5
14.0
5 -
14.2
0
14.2
0 -
14.3
5
14.3
5 -
14.5
0
14.5
0 -
13.0
5
13.0
5 -
15.3
0
12.0
5 -
12.2
5
12.2
5 -
12.4
5
12.4
5 -
13.0
5
13.0
5 -
13.1
5
GOLD
EN
HALL
BALL
RO
OM
GOLD
EN
HALL
L2-1
MRI
as
a di
agno
stic
tool
for e
ndom
etrio
sis
G
erar
d Du
nsel
man
(NL)
L2-2
Ultr
asou
nd a
s a
diag
nost
ic to
ol fo
r end
omet
riosi
s
Mau
ricio
Abr
ao (B
R)
L2-3
The
futu
re o
f sur
gery
as
a tr
eatm
ent o
f end
omet
riosi
s
Jor
g Ke
ckst
ein
(AT)
L2-4
Tar
gete
d tr
eatm
ents
for e
ndom
etrio
sis
L
inda
Giu
dice
(US)
Ques
tions
and
ans
wer
s
GOLD
EN
HALL
A lig
ht lu
nch
will b
e se
rved
25
Frid
ay 2
May
201
4 1
5.30
- 1
8.30
16.0
0 –
16.1
2
16.1
2 –
16.2
4
16.2
4 –
16.3
6
16.3
6 –
16.4
8
Med
ical
ther
apy
Chai
rs |
Vivia
n Fe
rreira
do
Amar
al (B
R)
and
Thom
as D
’Hoo
ghe
(BE)
Diag
nosi
s an
d sc
reen
ing
Chai
rs |
Lind
a Gi
udic
e (U
S) a
nd
Anto
nio
Setu
bal (
PT)
Imm
unol
ogy
and
stem
cel
lsCh
airs
| Ta
suku
Har
ada
(JP)
and
Lo
uise
Hul
l (AU
)
Qual
ity o
f life
Chai
rs |
Neil
John
son
(NZ)
and
Ca
rlos
Calh
az-J
orge
(PT)
S4-2
The
asso
ciat
ion
of p
ycno
geno
l with
or
al c
ontr
acep
tives
for t
he tr
eatm
ent
of e
ndom
etrio
sis-
rela
ted
pain
Hugo
Mai
a Jr
. (BR
)
S4-1
Ar
e w
e fo
llow
ing
our n
atio
nal
endo
met
riosi
s cl
inic
al p
ract
ice
guid
elin
es?
A
Cana
dian
per
spec
tive
Mar
a So
bel (
CA)
S5-1
Th
e ro
le o
f the
gen
eral
pra
ctiti
oner
in th
e di
agno
stic
pro
cess
of D
utch
wom
en w
ith
endo
met
riosi
s
Anne
mie
k Na
p (N
L)
S4-3
Upda
te o
n ch
ange
s in
bon
e de
nsity
in
wom
en w
ith s
ympt
omat
ic e
ndom
etrio
sis
durin
g an
d af
ter t
reat
men
t with
leup
rolid
e ac
etat
e an
d no
reth
indr
one
acet
ate
Pam
ela
Stra
tton
(US)
S4-4
An a
ntip
roge
stin
, Cdb
-412
4, im
pact
s cy
clin
g an
d ho
rmon
es w
hich
may
lead
to a
llevi
atio
n of
sym
ptom
s of
end
omet
riosi
s
Rona
ld W
iehl
e (U
S)
S5-2
Dela
y in
clin
ical
dia
gnos
is o
r del
ay in
re
ferr
al fo
r ade
quat
e tr
eatm
ent:
Whi
ch h
as
a gr
eate
r im
pact
on
the
man
agem
ent o
f en
dom
etrio
sis?
David
Sor
iano
(IL)
S5-3
Com
mun
icat
ing
endo
met
riosi
s w
ith y
oung
w
omen
to d
ecre
ase
diag
nosi
s tim
e
Mel
issa
Par
ker (
AU)
S5-4
Eval
uatio
n of
the
biom
arke
r He4
as
a
diffe
rent
ial t
ool i
n pa
tient
s w
ith d
iffer
ent
stag
es o
f end
omet
riosi
s an
d ov
aria
n ca
ncer
Dorth
e Ha
rtwel
l (DK
)
S6-2
Char
acte
rizat
ion
of th
e su
bpop
ulat
ions
of
topi
c en
dom
etrio
tic ti
ssue
– a
put
ativ
e en
dom
etrio
tic s
tem
cel
l pop
ulat
ion?
Adria
na In
vitti
(BR)
S6-3
Regu
lato
ry T
cel
ls in
end
omet
riosi
s:
Pote
ntia
l rol
es in
pat
hoge
nesi
s
Mar
ina
Berb
ic (A
U)
S6-4
The
endo
met
rial s
tem
cel
l mar
kers
not
ch
and
num
b ar
e as
soci
ated
with
end
omet
riosi
s
Mar
tin G
ötte
(DE)
S7-2
En
dom
etrio
sis
impa
ct q
uest
ionn
aire
(Eiq
): Ne
w q
uest
ionn
aire
to m
easu
re lo
ng te
rm
impa
ct o
f end
omet
riosi
s on
wom
en’s
live
s
Mar
yam
Mor
adi (
AU)
S7-3
Th
e in
fluen
ce o
f dys
pare
unia
and
dy
smen
orrh
ea in
tens
ities
on
diffe
rent
do
mai
ns o
f wom
en’s
qua
lity
of li
fe q
uant
ified
th
roug
h SF
-36
and
EHP-
30 q
uest
ionn
aire
s
Mar
lon
de F
reita
s Fo
nsec
a (B
R)
S7-4
Af
fect
ed s
exua
l fun
ctio
ning
In w
omen
with
en
dom
etrio
sis
influ
ence
s se
xual
func
tioni
ng
of th
eir m
ale
part
ner a
nd le
ads
subs
eque
ntly
to
unc
erta
inty
In th
eir r
elat
ions
hip
Ai
sha
de G
raaf
f (NL
)
GOLD
EN
HALL
BALL
RO
OM 4
BALL
RO
OM 1
BALL
RO
OM 2
-3
Refr
eshm
ents
, pos
ter v
iew
ing
and
exhi
bits
15.3
0 -
16.0
0
S6-1
Ne
rve
repe
llent
fact
ors
affe
ct th
e in
flam
mat
ory
cond
ition
of e
ndom
etrio
sis
Sylvi
a M
echs
ner (
DE)
S7-1
Pe
rson
ality
cor
rela
tes
of e
ndom
etrio
sis
Yuva
l Kau
fman
(IL)
16.4
8 –
17.0
0
17.0
0 –
17.1
2
17.1
2 –
17.2
4
17.2
4 –
17.3
0
S4-5
Prot
ein
kina
se in
hibi
tor v
emur
afen
ib
cont
rols
the
prog
ress
ion
of e
ndom
etrio
sis
in
vitr
o an
d in
viv
o Pi
etro
San
tulli
(FR)
S5-5
Com
paris
on b
etw
een
tran
svag
inal
ultr
asou
nd
with
bow
el p
repa
ratio
n an
d pe
lvic
mag
netic
re
sona
nce
imag
ing
for t
he d
iagn
osis
of d
eep
endo
met
riosi
s Ro
sa M
aria
Nem
e (B
R)
S6-5
Cyto
kine
rela
ted
to n
atur
al k
iller
and
T-
regu
lato
ry c
ells
hav
e a
diffe
rent
pro
file
in
dee
p en
dom
etrio
sis
Patri
ck B
elle
lis (B
R)
S7-5
Or
al p
rese
ntat
ion
- A lo
ng te
rm p
rosp
ectiv
e ob
serv
atio
nal s
tudy
of t
he im
pact
of
lapa
rosc
opic
exc
isio
n of
end
omet
riosi
s
on q
ualit
y of
life
par
amet
ers
King
shuk
Maj
umde
r (UK
)
S4-6
Long
term
trea
tmen
t with
letr
ozol
e af
ter
gnrh
a do
wn
regu
latio
n in
pre
men
opau
sal
wom
en w
ith m
oder
ate
and
seve
re
endo
met
riosi
s. A
saf
ety
and
effic
acy
stud
y Ju
lia B
artle
y (D
E)
S4-7
Eval
uatio
n of
the
effic
acy
of tw
o di
ffere
nt
oral
con
trac
eptiv
e fo
rmul
atio
ns a
dmin
iste
red
in a
con
tinuo
us fa
shio
n fo
r mod
erat
e to
se
vere
dys
men
orrh
ea: P
relim
inar
y re
sults
Th
iago
Per
eira
(BR)
S5-6
Thre
e-di
men
sion
al re
ctos
onog
raph
y:
Desc
riptio
n an
d ev
alua
tion
of a
3D
tr
ansv
agin
al e
chog
raph
y w
ith c
ontr
ast t
o as
sess
col
orec
tal e
ndom
etrio
sis
Gil D
uber
nard
(FR)
S5-7
Eval
uatio
n of
pla
sma
mic
rorn
as a
s
diag
nost
ic b
iom
arke
rs fo
r end
omet
riosi
s Zh
ao W
ang
(AU)
S6-6
Dend
ritic
cel
ls, t
he m
enst
rual
cyc
le a
nd
endo
met
riosi
s: C
ircul
atin
g an
d en
dom
etria
l po
pula
tions
Alis
on H
ey-C
unni
ngha
m (A
U)
S6-7
Expr
essi
on o
f ang
iote
nsin
rece
ptor
s
type
1 (A
t1)
type
2 (A
t2) M
rna
in lo
cal
endo
met
riosi
s le
sion
s
Take
hiro
Nak
ao (J
P)
S7-6
Di
ffere
nces
in p
ain
repo
rtin
g an
d
man
agem
ent b
etw
een
thre
e ge
ogra
phic
al
regi
ons
in a
cro
ss-s
ectio
nal s
tudy
in
patie
nts
with
end
omet
riosi
s (fe
elin
g)
Char
les
Chap
ron
(FR)
S7-7
Pr
eope
rativ
e SF
36 s
core
to d
ecid
e
a su
rgic
al a
ppro
ach
in p
atie
nt w
ith
chro
nic
pelv
ic p
ain
Mic
hel C
anis
(FR)
Post
er s
essi
on w
ith re
fres
hmen
ts
GOLD
EN
HALL
BALL
RO
OM 4
BALL
RO
OM 1
BALL
RO
OM 2
-3
Diag
nosi
s an
d sc
reen
ing
Chai
rs |
Lind
a Gi
udic
e (U
S) a
nd
Anto
nio
Setu
bal (
PT)
Imm
unol
ogy
and
stem
cel
lsCh
airs
| Ta
suku
Har
ada
(JP)
and
Lo
uise
Hul
l (AU
)
Qual
ity o
f life
Chai
rs |
Neil
John
son
(NZ)
and
Ca
rlos
Calh
az-J
orge
(PT)
Med
ical
ther
apy
Chai
rs |
Vivia
n Fe
rreira
do
Amar
al (B
R)
and
Thom
as D
’Hoo
ghe
(BE)
27
Satu
rday
3 M
ay 2
014
08.
00 -
11.
30
08.0
0 –
08.2
0
08.2
0 –
08.3
5
08.3
5 –
08.5
0
08.5
0 –
09.0
5
09.0
5 –
09.2
0
09.2
0 –
09.3
5
09.3
5 –
10.0
0
10.0
0 –
10.3
0Re
fres
hmen
ts, p
oste
r vie
win
g an
d ex
hibi
ts
Endo
met
riosi
s an
d ca
ncer
Chai
rs |
Ludw
ig K
iese
l (DE
) and
Lin
da G
riffit
h (U
S)M
9-0
Endo
met
riosi
s an
d ca
ncer
Br
uno
Borg
hese
(FR)
Prev
entio
n an
d m
anag
emen
t of r
ecur
renc
esCh
airs
| M
ette
Moe
n (N
O) a
nd J
ohan
nes
Ever
s (N
L)M
10-0
Pr
even
tion
and
man
agem
ent o
f rec
urre
nces
Ka
ori K
oga
(JP)
M9-
1 Cl
inic
al a
naly
sis
of o
varia
n ep
ithel
ial c
arci
nom
a w
ith c
oexi
stin
g
pelv
ic d
ndom
etrio
sis
Lin
Qiu
(CN)
M9-
4
Mm
p-3
med
iate
d en
dom
etrio
tic s
igna
lling
: Goo
d or
evi
l?
Pram
athe
s Da
sMah
apat
ra (I
N)
M10
-2
Occu
lt en
dom
etrio
sis:
An
unde
tect
able
find
ing
by la
paro
scop
y in
nor
mal
per
itone
um
Khal
eque
Kha
n (J
P)
M9-
5
Do O
varia
n ca
ncer
and
end
omet
riosi
s –
Shar
ing
alte
red
gene
tic p
athw
ays?
Da
niel
Den
tillo
(BR)
M10
-4
The
asso
ciat
ion
betw
een
sym
ptom
s an
d su
rgic
al fi
ndin
gs in
wom
en w
ith s
uspe
cted
end
omet
riosi
sa
Uche
Men
akay
a (A
U)
M10
-5
Anti-
angi
ogen
esis
of g
reen
tea
and
pote
ntia
ls o
f pro
drug
of e
piga
lloca
tchi
n-3-
galla
te (P
ro-E
gcg)
as
a n
ovel
ant
i-ang
ioge
nesi
s ag
ent f
or e
ndom
etrio
sis
Ch
i Chi
u W
ang
(HK)
Ques
tions
, ans
wer
s an
d di
scus
sion
s on
futu
re re
sear
ch p
riorit
ies
Brun
o Bo
rghe
se (F
R)
Ques
tions
, ans
wer
s an
d di
scus
sion
s on
futu
re re
sear
ch p
riorit
ies
Kaor
i Kog
a (J
P)
M10
-3
Endo
met
riotic
lesi
ons
reca
pitu
late
wou
nd h
ealin
g by
recr
uitin
g pl
atel
ets
Su
n-W
ei G
uo (C
N)
M9-
2
Endo
met
riosi
s an
d ca
ncer
: How
sho
uld
we
look
to th
is a
ssoc
iatio
n? B
af25
0A
and
canc
er-r
elat
ed c
hem
okin
es e
xpre
ssio
n in
end
omet
riosi
s le
sion
s an
d pe
lvic
ly
mph
nod
es
Giul
iano
Bor
relli
(BR)
M9-
3
Endo
met
riosi
s an
d ov
aria
n ca
ncer
: An
inte
rnat
iona
l poo
led
anal
ysis
Ro
berta
Nes
s (U
S)
M10
-1
Endo
met
riosi
s: A
n in
tern
atio
nal h
ealth
issu
e to
o bi
g to
igno
re -
pre
vent
ive
prog
ram
s in
tegr
al to
a m
ulti-
disc
iplin
ary
appr
oach
to tr
eatm
ent,
a Ne
w Z
eala
nd m
odel
De
bora
h Bu
sh (N
Z)
GOLD
EN
HALL
BALL
RO
OM
10.3
0 –
10.4
2
10.4
2 –
10.5
4
10.5
4 –
11.0
6
11.0
6 –
11.1
8
Endo
met
rium
Chai
rs |
Hila
ry C
ritch
ley
(UK)
an
d W
arre
n No
thni
ck (U
S)
Epid
emio
logy
Chai
rs |
Stac
ey M
issm
er (U
S)
and
Mic
hel M
uelle
r (CH
)
Gene
tics,
epi
gene
tics,
an
d he
redi
tary
asp
ects
Chai
rs |
Andr
ew H
orne
(UK)
and
Ser
gio
Podg
aec
(BR)
Vide
o Se
ssio
n 2
Chai
rs |
Regi
nald
o Lo
pes
(BR)
an
d Ta
mer
Sec
kin
(US)
S8-2
Alte
red
mol
ecul
ar p
heno
type
s of
eut
opic
en
dom
etria
l mes
ench
ymal
ste
m c
ells
and
st
rom
al fi
brob
last
s in
end
omet
riosi
s
Lind
a Gi
udic
e (U
S)
S8-1
Ra
tiona
l des
ign
of s
ynth
etic
ext
race
llula
r m
atrix
(Ecm
) mic
roen
viro
nmen
ts th
at fo
ster
en
dom
etria
l epi
thel
ial c
ell p
olar
ity, f
unct
ion,
an
d st
rom
al c
ross
talk
for i
n vi
tro
and
in
vivo
use
Lind
a Gr
iffith
(US)
S9-1
En
dom
etrio
sis
rela
ted
qual
ity o
f lif
e ou
tcom
es a
re h
ighl
y in
fluen
ced
by
recr
uitm
ent s
trat
egie
s
Aish
a de
Gra
aff (
NL)
S8-3
The
orig
ins
of p
roge
ster
one
resi
stan
ce in
en
dom
etrio
sis:
sile
ncin
g of
pro
gest
eron
e ac
tion
at m
enst
ruat
ion
Bruc
e Le
ssey
(US)
S8-4
Mic
rorn
a M
ir-14
2-3P
regu
late
s
proi
nflam
mat
ory
sign
alin
g in
en
dom
etria
l str
oma
cells
Mar
tin G
ötte
(DE)
S9-2
Smok
ing
effe
cts
on p
ain
sym
ptom
s an
d fe
rtili
ty in
pat
ient
s w
ith e
ndom
etrio
sis
Luci
ana
Anto
niol
li (B
R)
S9-3
Inci
denc
e an
d co
st o
f sur
gery
for
endo
met
riosi
s in
Can
ada
iden
tified
us
ing
a na
tiona
l dat
abas
e
Cath
erin
e Al
laire
(CA)
S9-4
Endo
met
riosi
s he
alth
car
e: D
ispa
ritie
s in
ac
cess
to c
are
in w
omen
from
Pue
rto
Rico
Jess
ica
Four
quet
(PR)
S10-
2Ep
igen
etic
and
gen
omic
ana
lyse
s of
hu
man
feta
l mem
bran
es fr
om p
regn
ant
endo
met
riosi
s-af
fect
ed w
omen
Loui
s M
arce
llin (F
R)
S10-
3Ge
nom
e-w
ide
anal
ysis
of m
ethy
lom
e
reve
als
larg
e ep
igen
etic
alte
ratio
ns
in e
ndom
etrio
sis
Brun
o Bo
rghe
se (F
R)
S10-
4Ab
erra
nt d
na m
ethy
latio
n pr
ofile
s an
d pa
ttern
s of
hum
an e
utop
ic e
ndom
etriu
m in
en
dom
etrio
sis
and
its a
ssoc
iatio
n w
ith o
ther
re
gula
tory
ele
men
ts
Saha
r Hou
shda
ran
(US)
V2-2
Ca
se re
port
of a
bdom
inal
wal
l en
dom
etrio
sis
man
aged
lapa
rosc
opic
ally
Rodr
igo
Fern
ande
s (P
T)
V2-3
Su
rgic
al tr
eatm
ent o
f bla
dder
en
dom
etrio
sis
asso
ciat
ed w
ith
exte
rnal
ade
nom
yosi
s
Patri
ck B
elle
lis (B
R)
V2-4
Ro
botic
app
roac
h fo
r the
trea
tmen
t of t
he
ovar
ian
dndo
met
riom
a - T
he te
chni
que
Duar
te R
ibei
ro (B
R)
GOLD
EN
HALL
BALL
RO
OM 4
BALL
RO
OM 1
BALL
RO
OM 2
-3
S10-
1
Over
expr
essi
on o
f P27
Kip1
in c
ultu
red
endo
met
rial c
ells
from
pat
ient
s w
ith
endo
met
riosi
s no
rmal
izes
ang
ioge
nic
fact
ors
expr
essi
on
Adria
na In
vitti
(BR)
V2-1
A
new
exc
isio
n pr
oced
ure
for l
ow a
nd
mid
rect
al e
ndom
etrio
sis
nodu
les
usin
g co
mbi
ned
tran
sana
l and
lapa
rosc
opic
ap
proa
ch
Hora
ce R
oman
(FR)
11.1
8 –
11.3
0
10.4
2 –
10.5
4
S8-5
De
crea
se in
not
ch 1
con
trib
utes
to
impa
ired
deci
dual
izat
ion
asso
ciat
ed
with
end
omet
riosi
s
Asgi
Faz
leab
as (U
S)
S9-5
Pe
lvic
infla
mm
ator
y di
seas
e in
wom
en
with
end
omet
riosi
s is
mor
e se
vere
than
in
thos
e w
ithou
t
David
Sor
iano
(IL)
S10-
5
Varia
bilit
y of
gen
ome-
wid
e ge
ne
expr
essi
on a
nd d
na m
ethy
latio
n va
lues
ac
ross
tiss
ue s
ampl
es fr
om w
omen
with
an
d w
ithou
t end
omet
riosi
s
Alex
ande
r W D
rong
(UK)
V2-5
St
anda
rdiz
atio
n of
vid
eola
paro
scop
ic
surg
ery
for d
eep
endo
met
riosi
s by
co
lore
ctal
sur
geon
Univa
ldo
Saga
e (B
R)
29
27 Satu
rday
3 M
ay 2
014
11.
30 -
15.
15
11.3
0 –
11.4
2
11.4
2 –
11.5
4
Endo
met
rium
Chai
rs |
Hila
ry C
ritch
ley
(UK)
an
d W
arre
n No
thni
ck (U
S)
Epid
emio
logy
Chai
rs |
Stac
ey M
issm
er (U
S)
and
Mic
hel M
uelle
r (CH
)
Gene
tics,
epi
gene
tics,
an
d he
redi
tary
asp
ects
Chai
rs |
Andr
ew H
orne
(UK)
and
Ser
gio
Podg
aec
(BR)
Vide
o Se
ssio
n 2
Chai
rs |
Regi
nald
o Lo
pes
(BR)
an
d Ta
mer
Sec
kin
(US)
S8-6
Prot
ein
oxid
atio
n le
vels
and
sup
erox
ide
dism
utas
e ac
tivity
in w
omen
with
infe
rtili
ty
rela
ted
to e
ndom
etrio
sis
Mar
icel
a Vi
ola-
Rhen
als
(CO)
S9-6
En
dom
etrio
tic w
omen
pre
sent
an
in
crea
sed
prev
ious
spo
ntan
eous
ab
ortio
ns ra
te
Piet
ro S
antu
lli (F
R)
S8-7
Dete
ctio
n of
ner
ve fi
bers
in e
ndom
etriu
m
topi
c to
aid
in th
e di
agno
sis
of e
ndom
etrio
sis
Mig
uel G
obbi
(BR)
S9-7
Bene
fits
of o
ral c
ontr
acep
tives
in
dysm
enor
rhea
and
dys
pare
unia
: Ca
se-c
ontr
ol s
tudy
in m
edic
al s
tude
nts
of
Coi
mbr
a un
iver
sity
, Por
tuga
l
Mar
garid
a Di
as (P
T)
S10-
7Va
lidat
ion
of h
isto
ne 3
and
his
tone
4 ly
sine
tr
i-met
hyla
tion
stat
us o
f end
omet
riosi
s le
sion
s
Jani
ce B
arro
s-M
onte
iro (P
R)
V2-7
Up
date
on
robo
tics
and
endo
met
riosi
s –
Wha
t is
the
curr
ent s
tate
?
Char
les
Mille
r (US
)
GOLD
EN
HALL
BALL
RO
OM 4
BALL
RO
OM 1
BALL
RO
OM 2
-3
S10-
6
An It
alia
n as
soci
atio
n st
udy
confi
rms
prev
ious
gw
as d
ata
supp
ortin
g ve
zt a
s su
scep
tibili
ty lo
cus
for e
ndom
etrio
sis
Paol
a Vi
gano
(IT)
V2-6
St
age
Iv e
ndom
etrio
sis
and
left
uter
olys
is
Taha
ni A
lmot
rafi
(AU)
12.1
5 –
13.1
5
12.3
5 –
12.5
5
The
role
of m
enst
rual
infl
amm
atio
n in
the
path
ogen
esis
of e
ndom
etrio
sis
sym
ptom
s an
d th
e ef
ficac
y of
con
tinuo
us re
gim
ens
of o
ral
cont
race
ptiv
es to
indu
ce a
men
orrh
ea
Hugo
Mai
a (B
R)
The
impa
ct o
f am
enor
rhea
on
the
qual
ity o
f life
of e
ndom
etrio
sis
patie
nts
Elia
no P
ellin
i (BR
)
The
impo
rtan
ce o
f am
enor
rhea
in th
e m
anag
emen
t of e
ndom
etrio
sis
Spon
sore
d by
BALL
RO
OM BALL
RO
OM
13.3
0 –
14.0
0
14.0
0 –
14.3
0
14.3
0 -
15.1
5
Keyn
ote
lect
ure
5
Chai
rs |
David
Ada
mso
n (U
S) a
nd L
uk R
omba
uts
(AU)
WER
F EP
Hect
: glo
bal h
arm
onis
atio
n of
rese
arch
St
acey
Mis
smer
(US)
Keyn
ote
lect
ure
6
Chai
rs |
Paul
o Ay
roza
Gal
vao
Ribe
iro (B
R) a
nd R
onal
d Ba
tt (U
S)
Defin
itive
sur
gery
: why
, whe
n, a
nd h
ow?
To
mm
aso
Falc
one
(US)
Clos
ing
Cere
mon
y
12.5
5 -
13.1
5Qu
estio
ns a
nd a
nsw
ers
A lig
ht lu
nch
will b
e se
rved
12.1
5 –
12.3
5
BALL
RO
OM
BALL
RO
OM
Closing ceremony
CHAIRS | Neil Johnson (NZ), Mauricio Abrao (BR) and Linda Giudice (US)
14.30
14.45
15.00
15.15
Summary of the highlights of WCE2014 and presentation on behalf of SBE of the award for best video presentation Rui Ferriani (BR)
Turning over a new leaf: welcome to the 13th World Congress on Endometriosis in 2017 Catherine Allaire (CA)
Close
Presentation of the Rodolphe Maheux and David Healy Awards Linda Giudice (US)
Thank you Mauricio Abrao (BR)
14.55
Exhi
bito
r
Stan
d #
Abbv
ie
21
Amge
n
4
Astra
Zene
ca
1
Baye
r Hea
lthca
re
19
ConM
ed
Ta
ble
Covid
ien
20
Ethi
con
5
Livr
aria
Reb
ram
ed
Tabl
e
Patie
nt S
ocie
ties
3
Stor
z
17
Stra
ttner
16
WCE
2017
18
SBE
2
32
Exhi
bito
r / p
oste
r floo
r pla
n
WCE2014 Sponsors
AbbvieAbbVie is a global, research-based biopharmaceutical company formed
in 2013 following separation from Abbott. The company’s mission is to
use its expertise, dedicated people and unique approach to innovation
to develop and market advanced therapies that address some of the
world’s most complex and serious diseases. In 2013, AbbVie employs
approximately 21,000 people worldwide and markets medicines in
more than 170 countries. For further information on the company and
its people, portfolio and commitments, please visit www.abbvie.com.
Follow @abbvie on Twitter or view careers on our Facebook or Linke-
dIn page.
AbbVie Inc.
1 North Waukegan Road, North Chicago, IL 60064
USA
www.abbvie.com
33
AstraZeneca AstraZeneca is a global, innovation-driven biopharmaceutical business
that focuses on the discovery, development and commercialisation
of prescription medicines, primarily for the treatment of cardiovascular,
metabolic, respiratory, inflammation, autoimune, oncology, infection
and neuroscience diseases. AstraZeneca operates in over 100 countries
and its innovative medicines are used by millions of patients worldwide.
For more information please visit: www.astrazeneca.com
AstraZeneca do Brasil Ltda.
Rodovia Raposo Tavares, km 26,9 – Moinho Velho, Cotia/SP –
CEP: 06707-000
www.astrazeneca.com.br
Bayer HealthcareThe Bayer Group is a global enterprise with core competencies in the fields
of health care, agriculture and high-tech materials. Bayer HealthCare, a
subgroup of Bayer AG with annual sales of EUR 18.9 billion (2013), is one of
the world’s leading, innovative companies in the healthcare and medical
products industry and is based in Leverkusen, Germany. The company
combines the global activities of the Animal Health, Consumer Care,
Medical Care and Pharmaceuticals divisions. Bayer HealthCare’s aim is
to discover, develop, manufacture and market products that will improve
human and animal health worldwide. Bayer HealthCare has a global
workforce of 56,000 employees (Dec 31, 2013) and is represent-
ed in more than 100 countries. More information is available at
www.healthcare.bayer.com
Bayer Healthcare, Bayer Pharma AG
13342 Berlin, GERMANY
www.bayerpharma.com
BergamoBergamo, uma subsidiária Amgen
Av. das Nações Unidas, 14.171, 22º Andar,
Torre Crystal. Vl. Gertrudes.
São Paulo – SP – CEP: 04794-000
www.amgenbrasil.com.br
BMR Medical LtdaAv. Candido Hartmann, 570 Cj.174
Mercês
CEP 80.730-440
Curitiba,Paraná, Brasil
Industrial Site: BR 116, 400 (Km 1)
Campina Grande do Sul
www.bmrmedical.com.br
34
WCE2014 Sponsors
EthiconAt Ethicon, we’re working to redefine surgery to change the world
for the better. We share an enduring commitment to advance surgical
care so more patients live longer, more fulfilling lives. And we are con-
tinuously evolving to better serve our customers. This commitment is
founded upon three key ideas:
Partnering for meaningful solutions: For almost a century, from
leading-edge sutures and endocutters to comprehensive payor and
provider solutions.
Expanding care globally: With offices, R&D Centers and manufactur-
ing facilities in more than 50 countries around the world.
People making a lasting difference: Our associates dedicate their
time and put their passion into helping hundreds of communities and
organizations across the globe
ETHICON
Rua Gerivatiba, 207, 12º ao 15º andares, Butantã, São Paulo, SP
www.ethicon.com
Covidien Covidien is a leading global healthcare products company that creates
innovative medical solutions for better patient outcomes and delivers
value through clinical leadership and excellence.
Through to its many respected brands, including Autosuture, Valleylab,
and Kendall, and wide portfolio, we make doctors, nurses, pharmacists
and other medical professionals as effective as they can be by intro-
ducing new technology and products.
COVIDIEN
Av. Jornalista Roberto Marinho, 85 - 10º e 11º andares
Cidade Monções - São Paulo - SP
CEP: 04576-010
ConMedCONMED Corporation
525 French Road
Utica, NY 13502
USA
www.conmed.com
Karl Storz
KARL STORZ is a renowned manufacturer that is well established in
all fields of endoscopy and can be considered as market leader in rigid
endoscopy. The still family held company was founded in 1945 in Tut-
tlingen, Germany, and has grown to one with a worldwide presence and
6700 employees. KARL STORZ offers a range of both rigid and flexible
endoscopes for a broad variety of applications. Today’s product range
also includes fully integrated concepts for the OR and servicing.
KARL STORZ GmbH & Co. KG
Mittelstraße 8 D-78532 Tuttlingen
www.karlstorz.com
WCE2014 Sponsors
LibbsLibbs is a 100% brazilian laboratory that operates with an important
class of gynecologists. We have an expressive line of oral contraceptives
such as Gestinol 28, a gestodene 75mcg and 30mcg ethinylestradiol
association.
Libbs Farmacêutica Ltda
Rua Josef kryss, 250
São Paulo SP CEP: 01140-050
Brazil
www.libbs.com.br
Strattner H. Strattner Company is very proud to be part of the development of the
Brazilian Medicine focusing on Minimally Invasive Surgery (MIS). Since
1950, the company offers to Brazilian doctors the best MIS solutions
and products, exclusively representing worldwide medical devices
companies™ leaders: Karl Storz Endoskope, Storz Medical, MTP,
Intuitive Surgical, Medisafe, SciCan, Swann Morton, EDAP TMS, Trilux
and BK.
H. STRATTNER
Rua Ricardo Machado, 904 - São Cristóvão –
Rio de Janeiro- CEP: 20921-270
www.strattner.com.br
35
16.00 to 18.30List of presenters
Abrao, Mauricio
Adamson, David
Advincula, Arnold
Albertsen, Hans
Albuquerque, Maria Eugenia
Alkatout, Ibrahim
Allaire, Catherine
Almotrafi, Tahani
Antoniolli, Luciana
Arnold, Julia
Arosh, Joe
Attar, Erkut
Ballester, Marcos
Barros-Monteiro, Janice
Bartley, Julia
Becker, Christian
Bellelis, Patrick
Berbic, Marina
Presenters PresentersSessions Sessions Page Page
PCC3-1
OC
L2-2
CC
PCC6-8
PCC3-14
M1-4
PCC2-6
PCC5-4
S9-3
CC
V1-2
V2-6
S9-2
M5-1
M5-2
M6-0
S1-5
S10-7
S4-6
M7-0
V1-1
S6-5
V2-3
S6-3
15
19
25
30
16
15
20
15
16
28
30
22
27
28
24
24
24
23
30
27
25
22
27
29
26
Blasbalg, Roberto
Borghese, Bruno
Borrelli, Giuliano
Boujenah, Jeremy
Brandão, Alice
Brosens, Ivo
Bush, Deborah
Canis, Michel
Campana, Colette
Carmona, Francisco
Carnevale Marin, Maria Lucia
Ceccaroni, Marcello
Chapron, Charles
PCC1-3
PCC1-11
M9-0
S10-3
M9-2
S2-3
PCC1-4
K3-0
K4-0
M10-1
PCC1-1
M10-1
M2-2
PCC4-6
M2-0
M3-1
PCC3-5
PCC3-7
S1-4
PCC4-4
L1-3
B2-4
S7-6
14
14
28
29
28
22
14
24
25
28
14
19
20
15
20
21
15
15
22
15
21
24
27
36
16.00 to 18.30List of presenters
Clarizia, Roberto
Cohen, Jonathan
Collinet, Pierre
Cunha-Filho, Joao Sabino
Das Mahapatra, Pramathes
de Amaral, Vivian Ferreira
de Cicco, Carlo
de Conto, Emily
de Freitas Fonseca, Marlon
de Graaff , Aisha
de Mattos, Leandro Accardo
de Nicola, Ana Luisa Alencar
de Ziegler, Dominique
Dentillo, Daniel
Dias, Margarida
Dias, Junior Joao Antonio
Drong, Alexander W
Dubernard, Gil
Dunselman, Gerard
Falcone, Tommaso
Fazleabas, Asgi
PCC3-6
M2-4
S1-7
S2-2
M8-3
PCC6-7
M9-4
PCC6-2
PCC3-10
S2-7
S7-3
S7-4
S9-1
PCC1-2
PCC1-7
PCC1-3
PCC6-3
M9-5
S9-7
PCC6-4
S10-5
S5-6
L2-1
K6-0
S8-5
Presenters PresentersSessions Sessions Page Page
15
20
22
22
25
16
28
16
15
23
26
26
29
14
14
14
16
28
29
16
29
27
25
30
29
Fernandes, Luiz
Fernandes, Rodrigo
Ferriani, Rui
Fischer, Oliver Martin
Fourquet, Jessica
Francisco, Antonio
Gargett, Caroline
Giudice, Linda
Gobbi, Miguel
Godlee, Fiona
Gomez, Raul
Goncalves, Manoel
Götte, Martin
Greaves, Erin
Griffith, Linda
PCC4-2
M8-1
V2-2
PCC6-5
CC
B2-1
S9-4
S3-4
M3-2
L2-4
M7-5
S8-2
CC
S8-7
OC
M7-4
PCC1-5
PCC1-12
PCC5-10
M3-4
S6-4
S8-4
M5-4
M3-5
S8-1
15
25
29
16
30
24
29
22
21
25
25
29
30
29
19
25
14
14
16
21
26
29
24
21
29
37
16.00 to 18.30List of presenters
Guo, Sun-Wei
Haas, Dietmar
Hartwell, Dorthe
Hey-Cunningham, Alison
Holland, Tom
van der Houwen, Lisette
Houshdaran, Sahar
Huhtinen, Kaisa
Ibrahim, Mohamed
Invitti, Adriana
Johnson, Neil
Kaufman, Yuval
Keckstein, Jörg
Khan, Khaleque
Kho, Rosanne
Kiesel, Ludwig
Klautau, Ana Paula
Koga, Kaori
Krentel, Harald
Kuepker, Wolfgang
M10-3
PCC5-6
M8-2
S5-4
S6-6
PCC1-9
M7-1
S2-6
S10-4
S3-1
M2-1
S6-2
S10-1
S2-4
S7-1
PCC3-4
PCC3-11
L2-3
M2-3
M10-2
PCC3-15
PCC5-1
PCC2-4
M10-0
PCC5-3
PCC5-2
Presenters PresentersSessions Sessions Page Page
28
16
25
26
27
14
25
23
29
22
20
26
29
22
26
15
15
30
20
28
15
16
14
28
16
16
Kwon, Sang Hoon
Lasmar, Bernardo
Lee, Yie Hou
Leng, Jinhua
Lessey, Bruce
Lima, Doryane Maria Dos Reis
Maia Jr, Hugo
Majumder, Kingshuk
Malzoni, Mario
Marcellin , Louis
Matsumoto, Kanako
Mechsner, Sylvia
Menakaya, Uche
Mettler, Liselotte
Miller, Charles
Missmer, Stacey
Montgomery, Grant
Moradi, Maryam
Morris, Andrew
Mueller, Michel
Murray, Sarah
V1-4
M8-4
S2-5
S1-6
S8-3
M8-5
S4-2
L3-1
S7-5
PCC3-3
PCC3-13
S10-2
M2-5
M5-0
S6-1
M10-4
PCC5-4
V2-7
K5-0
M1-0
S7-2
M1-1
PCC5-5
L1-4
M5-5
22
25
23
23
29
25
26
30
27
15
15
29
20
24
26
28
16
30
30
20
26
20
16
21
24
38
16.00 to 18.30List of presenters
Myung, Lydia
Nakao, Takehiro
Nap, Annemiek
Navarro, Paula
Neme, Rosa Maria
Ness, Roberta
Ng, Juki
Ng, Cecilia
Nishimoto-Kakiuchi, Ayako
Nyegaard, Mette
Oliveria, Marco Aurelio
Oppelt, Peter
Padovesi, Igor
Panina, Paola
Parker, Melissa
Pellini, Miguel
Pereira, Ana Maria
Pereira, Thiago
Petracco, Rafaella
Petraglia, Felice
Petta, Carlos
PCC2-2
S6-7
S5-1
PCC6-1
S5-5
M9-3
M6-2
M6-5
S3-7
M1-5
PCC3-8
PCC5-9
PCC2-1
M4-1
S3-6
M7-2
S5-3
L3-2
M4-4
S4-7
M4-5
PCC4-5
PCC4-7
PCC6-6
L1-6
Presenters PresentersSessions SessionsPage Page
14
27
26
16
27
28
24
24
23
20
15
16
14
21
23
25
26
30
21
27
21
15
15
16
21
Pina de Carvalho, Luiz Fernando
Podgaec, Sergio
Popov, Aleksander
Pouly, Jean Luc
Qiu, Lin
Rahmioglu, Nilufer
Ray, Kristeena
Reis, Fernando
Renner, Stefan
Ribeiro, Paulo Ayroza
Ribeiro, Duarte
Riiskjaer, Mads
Roman, Horace
Romano, Andrea
Romeo, Armando
Sagae, Univaldo
K1-0
S3-5
PCC1-8
PCC4-8
L1-1
S2-1
M9-1
M1-2
M5-3
K2-0
PCC5-8
PCC3-2
B1-2
V1-5
V2-4
S1-2
M4-3
M8-0
S1-1
V2-1
M6-4
PCC3-9
V1-6
V2-5
20
23
14
15
21
22
28
20
24
21
16
15
20
23
29
22
21
25
22
29
24
15
23
29
39
16.00 to 18.30List of presenters
Saha, Rama
Santulli, Pietro
Sardá, Jamir
Sarrel, Sallie
Schor, Eduardo
Seckin, Tamer
Sharpe-Timms, Kathy
Shebl, Omar
Singh, Sony
Singh, Vinay
Sobel, Mara
Somigliana, Edgardo
Soriano, David
Stepp, Kevin
Stratton, Pamela
Taylor, Hugh
Terrassani Silveira, Cássia Gisele
Thiruchelvam, Uma
Tsunada, Audrey
Uzan, Jennifer
M1-3
PCC4-1
S4-5
S9-6
PCC2-3
PCC2-5
PCC1-8
V1-7
S3-2
PCC5-7
PCC4-3
L1-5
M6-1
S4-1
M4-0
S5-2
S9-5
PCC3-12
S4-3
M3-0
M6-3
M3-3
B1-1
V1-3
Presenters PresentersSessions SessionsRooms Rooms
20
15
27
30
14
14
14
23
22
16
15
21
24
26
21
26
29
15
26
21
24
21
20
22
Vercellini, Paolo
Vigano, Paola
Vincent, Katy
Viola-Rhenals, Maricela
Wang, Zhao
Wang, Chi Chiu
Wiehle, Ronald
Wu, Clara
Xu, Bing
Yeung, Patrick Jr.
Young, Scott
Young, Vicky Jane
Zollner, Thomas M.
Zondervan, Krina
OC
S10-6
B2-2
S8-6
S5-7
M10-5
S4-4
S1-3
M4-2
M7-3
PCC1-10
S3-3
B2-2
L1-2
19
30
24
30
27
28
26
22
21
25
14
22
24
21
40
Save the date now for the next world event in endometriosis, presided over by Catherine Allaire with honorary president Victor Gomel.
www.endometriosis.ca/wce2017
1 3 T H W O R L D C O N G R E S S
Tu r n i n g o v e r a n e w l e a f
O N E N D O M E T R I O S I S
Where to go for lunchThe WTC Convention Centre offers a wide
variety of places to have lunch within the D&D
Decoration and Design Centre.
• Coffee shops and chocolate stores:
BonCafé, Kopenhagen.
• Fast Food:
Bon Grille, Gendai, Mc Donald’s,
Rizzo Gourmet, Viena Express and
Vivenda do Camarão.
• Restaurants:
Andiamo, Badaró, Barbacoa Grill,
Bon Restô and Sweet Pimenta.
Where to go for dinnerKaa Restaurante - Av. Juscelino
Kubitschek, 279 - Vila Olimpia
The Kaa restaurant - is inspired by the
French-Italian cuisine combined with Brazilian
ingredients. Situated in the bustling Juscelino
Kubitschek Avenue, it is recognized for its
stunning architecture.
Sky Bar - Restaurante do Hotel Unique
- Avenida Brigadeiro Luis Antonio, 4700 -
Jardim Paulista
Located on the rooftop of the hotel, Skye
boasts a crimson red pool with an underwater
sound system and lounge area with stunning
views over Ibirapuera Park and the entire São
Paulo skyline. At Skye, innovative, delicious
food and drink by Chef Emmanuel Bassoleil,
visual exuberance, and legendary Unique
service engage all the senses.
Figueira Rubaiyat - R. Hadock Lobo, 1738 -
Cerqueira César
It is a restaurant postcard because of the
giant fig tree and Centennial, whose branches
spread throughout the hall that can be seen
from the street.
Barbacoa Churrascaria - Av. das Nações
Unidas, 12.555 – Piso Boulevard – Loja 122 e
124 - Brooklin - Event Location
Barbacoa is a chain of steakhouses, and the
D&D is located within one of São Paulo’s
busiest malls. It features an exclusive outside
entrance and valet parking. It offers more than
20 different cuts of beef, seafood and poultry
served a la carte, plus a salad buffet with more
than 40 ingredients.
What to do in São PaoloSão Paulo is a rich and vibrant city, not only
the commercial capital of Brazil, but also one
of the most culturally diverse cities in South
America. São Paulo is host to not only to
Brazilians, but also a host of other nations,
including the largest settlement of Japanese
people outside of Japan.
Here are a few ideas of experiences of this
magnificent city that you can gain whilst here
for the congress:
MASP (Museu de Arte de São Paulo)
São Paulo has many great museums, but
MASP is the city’s best art museum. It holds
the finest collection of Western art in Latin
America and hosts fantastic temporary
exhibitions. Tuesdays are free to the public.
Pinacoteca do Estado
Another lovely museum in São Paulo, the Pina-
coteca houses a huge collection of Brazilian art
that serves as a visual story of the country’s
history and cultural evolution, as well as a nice
collection of 19th century French sculpture.
The museum has a beautiful café downstairs
and is connected to Parque da Luz, a public
park that includes outdoor sculptures and a
European-style garden area (that are shared
with some unusual characters).
Soccer Museum
The Museu de Futebol is located in Estadio
Pacaembu, one of the city’s largest soccer
stadiums. If you love soccer, you will enjoy the
vintage soccer displays, interactive exhibits,
and celebrations of World Cup history and
Brazilian soccer stars. As you exit, there is a
nice gift shop and a café with live music on
most weekends. Admission is about $3 and
the museum is open Tuesday to Sunday.
Benedito Calixto all-day market
on Saturdays
The Calixto outdoor market goes all day on
Saturdays, with antiques and handicrafts
vendors starting in the morning and live music
and dancing starting around noon in the
market’s central food court. The live music is
chorinho, a very Brazilian style of music that is
samba-influenced, and many people go to the
market just for this.
Emergency telephone numbersTherefore please ensure you keep your
belongings with you at all times and refrain
from carrying laptops, cameras and electronic
devices whilst outside. Emergency
numbers as follows:
• 11- Area code (São Paulo City
and metropolitan area)
• 192 – Health Emergency
• 190 – Military Police
• 147 – Civil Police
• 193 – Fire Department
42
Local information
O NOSSO NOME É NOVO. O NOSSO COMPROMISSO PARA COM OS CUIDADOS DE SAÚDE NÃO PRECISA DE APRESENTAÇÃO.Poucas empresas chegam ao mundo tão preparadas para servir os doentes como a AbbVie. Somos uma nova empresa biofarmacêutica, emergindo da Abbott com uma história de 125 anos de cuidados de saúde aos doentes.
Para fazer evoluir a saúde global, a AbbVie une a experiência e a estabilidade de uma empresa farmacêutica de sucesso com o espírito científico inovador de uma empresa de biotecnologia. O nosso compromisso de oferecer soluções que têm um impacto notável na vida das pessoas continua o legado das nossas origens da Abbott.
Estamos orgulhosos de nos apresentarmos como AbbVie, mas nunca nos esquecemos de que o que fazemos é mais importante do que o nosso nome.
abbvie.pt
OUR NAME IS NEW. OUR COMMITMENT TO HEALTHCARE WILL NEED NO INTRODUCTION.Few enterprises arrive in the world as ready to serve patients as AbbVie. We are a new biopharmaceutical company, emerging from Abbott with a 125-year history of patient care.
To advance global healthcare, AbbVie unites the expertise and stability of a successful pharmaceutical company with the innovative scientific spirit of a biotech. Our commitment to deliver solutions that make a remarkable impact in people’s lives continues the legacy of our Abbott origins.
We’re proud to introduce ourselves as AbbVie, but we never forget that what we do is more important than what we’re named.
abbvie.com
© 2014 AbbVie Inc.
AbbVie Inc.1 North Waukegan RoadNorth Chicago, IL 60064United States of AmericaTel: +1 847.932.7900Fax: +1 302.655.5049
Bayer welcomes you to São Paulo for
Lunchtime Symposium
Golden Hall11h45–13h15, Thursday 01 May 2014
Endometriosis management: individualization and the role of
Allurene®/Visanne®* (dienogest, 2mg)
Faculty: Carlos Petta (Brazil), Aleksandr Popov (Russia), Krina Zondervan (UK), Charles Chapron (France), Michael Mueller (Switzerland), Sony Singh (Canada)
*Visanne® is the international commercial name for Allurene®
Symposia sponsored by Bayer HealthCare
The World Congress on Endometriosis
G.WH.GT.03.2014.0053
ALLURENE®. DIENOGESTE. REG. MS – 1.7056.0088. INDICAÇÃO: TRATAMENTO DA ENDOMETRIOSE. CONTRAINDICAÇÕES: DISTÚRBIO TROMBOEMBÓLICO VE NOSO EM ATIVIDADE, PRESENÇA OU HISTÓRICO DE DOENÇA CARDIOVASCULAR E ARTERIAL, DIABETES MELLITUS COM ENVOLVIMENTO VASCULAR, PRESENÇA OU HISTÓRICO DE DOENÇA HEPÁTICA GRAVE ENQUANTO OS VALORES DA FUNÇÃO HEPÁTICA NÃO RETORNAREM AO NORMAL, PRESENÇA OU HISTÓRICO DE TUMOR HEPÁTICO (BENIGNO OU MALIGNO), SUSPEITA OU DIAGNÓSTICO DE NEOPLASIAS DEPENDENTES DE HORMÔNIOS SEXUAIS, SANGRAMENTO VAGINAL NÃO DIAGNOSTICADO, HIPERSENSIBILIDADE À SUBSTÂNCIA ATIVA OU A QUALQUER UM DOS COMPONENTES DA FORMULAÇÃO. ADVERTÊNCIAS E PRECAUÇÕES: ANTES DE INICIAR O TRATAMENTO COM ALLURENE®, DEVE-SE EXCLUIR A POSSIBILIDADE DE GRAVIDEZ. DURANTE O TRATAMENTO COM ALLURENE® A OVULAÇÃO É INIBIDA NA MAIORIA DAS PACIENTES. ENTRETANTO, ALLURENE® NÃO É UM CONTRACEPTIVO E CASO SEJA NECESSÁRIO PREVENIR A GRAVIDEZ, AS PACIENTES DEVEM SER ORIENTADAS A UTILIZAR MÉTODOS CONTRACEPTIVOS NÃO HORMONAIS (POR EXEMPLO, MÉTODO DE BARREIRA). COM BASE NOS DADOS DISPONÍVEIS, O CICLO MENSTRUAL RETORNA AO NORMAL DENTRO DE 2 MESES APÓS O TÉRMINO DO TRATAMENTO COM ALLURENE®. EM MULHERES COM HISTÓRICO DE GRAVIDEZ EXTRAUTERINA OU DE ALTERAÇÃO DA FUNÇÃO DAS TUBAS UTERINAS, O USO DE ALLURENE® DEVE SER DECIDIDO APENAS APÓS CUIDADOSA AVALIAÇÃO DA RELAÇÃO RISCO/BENEFÍCIO. COMO ALLURENE® É UM MEDICAMENTO QUE CONTÉM SOMENTE PROGESTÓGENO, DEVEM SER CONSIDERADAS AS PRECAUÇÕES E ADVERTÊNCIAS DE TODOS OS MEDICAMENTOS QUE CONTEM SOMENTE PROGESTÓGENO, EMBORA NEM TODAS ESTEJAM BASEADAS EM ACHADOS DOS ESTUDOS CLÍNICOS REALIZADOS COM ALLURENE®. CASO QUALQUER UMA DAS CONDIÇÕES/FATORES DE RISCO DESCRITAS A SEGUIR ESTEJA PRESENTE OU SE AGRAVE, DEVE-SE REALIZAR UMA ANÁLISE INDIVIDUAL DA RELAÇÃO RISCO/BENEFÍCIO ANTES DE INICIAR OU CONTINUAR O USO DE ALLURENE®: DISTÚRBIOS CIRCULATÓRIOS, TUMORES, ALTERAÇÕES NO PADRÃO DE SANGRAMENTO, HISTÓRICO DE DEPRESSÃO, DESENVOLVIMENTO DE HIPERTENSÃO CLINICAMENTE SIGNIFICATIVA DIABETES MELLITUS (SOBRETUDO HISTÓRICO DE DIABETES MELLITUS GESTACIONAL), E OCORRÊNCIA FOLÍCULOS OVARIANOS PERSISTENTES (CISTOS OVARIANOS FUNCIONAIS). RECORRÊNCIA DE ICTERÍCIA COLESTÁTICA E/OU PRURIDO OCORRIDO ANTERIORMENTE DURANTE UMA GRAVIDEZ OU DURANTE O USO ANTERIOR DE ESTEROIDES SEXUAIS REQUER A DESCONTINUAÇÃO DE ALLURENE®. MULHERES COM TENDÊNCIA A MELASMA/CLOASMA DEVEM EVITAR EXPOSIÇÃO AO SOL OU RADIAÇÃO ULTRAVIOLETA DURANTE O TRATAMENTO COM ALLURENE®. RECOMENDA-SE ACOMPANHAMENTO REGULAR, COM ATENÇÃO ESPECIAL À PRESSÃO ARTERIAL,MAMAS, ABDOME E ÓRGÃOS PÉLVICOS, INCLUINDO CITOLOGIA CERVICAL. ALLURENE® NÃO DEVE SER ADMINISTRADO A MULHERES GRÁVIDAS UMA VEZ QUE NÃO HÁ NECESSIDADE DE TRATAR A ENDOMETRIOSE DURANTE A GRAVIDEZ - CATEGORIA B: “ESTE MEDICAMENTO NÃO DEVE SER UTILIZADO POR MULHERES GRÁVIDAS SEM ORIENTAÇÃO MÉDICA OU DO CIRURGIÃO-DENTISTA”. A ADMINISTRAÇÃO DE ALLURENE® DURANTE A LACTAÇÃO NÃO É RECOMENDADA. REAÇÕES ADVERSAS: FREQUENTES: CEFALEIA, DESCONFORTO NAS MAMAS, HUMOR DEPRIMIDO, ACNE, NÁUSEA, AUMENTO DE PESO, DOR ABDOMINAL, CISTO OVARIANO, CONDIÇÕES ASTÊNICAS, FLATULÊNCIA, FOGACHOS, DISTÚRBIOS DO SONO, IRRITABILIDADE, SANGRAMENTO UTERINO/VAGINAL INCLUINDO GOTEJAMENTO, NERVOSISMO, PERDA DE LIBIDO, ALOPECIA, DOR NAS COSTAS, DISTENSÃO ABDOMINAL, VÔMITO, ENXAQUECA, HUMOR ALTERADO. POUCO FREQUENTES: RESSECAMENTO VULVOVAGINAL, DESEQUILÍBRIO DO SISTEMA NERVOSO AUTÔNOMO, CANDIDÍASE VAGINAL, PELE SECA, ANSIEDADE, DEPRESSÃO, DISTÚRBIO DA ATENÇÃO, CONSTIPAÇÃO, DESCONFORTO ABDOMINAL, INFLAMAÇÃO GASTRINTESTINAL, HIPERIDROSE, PRURIDO, DIARREIA, INFECÇÃO DO TRATO URINÁRIO, CORRIMENTO GENITAL, DOR PÉLVICA, EDEMA, ANEMIA, DIMI NUIÇÃO DE PESO, AUMENTO DE APETITE, OLHO SECO, ZUMBIDO, DISTÚRBIOS INESPECÍFICOS DO SISTEMA CIRCULATÓRIO, PALPITAÇÕES, HIPOTENSÃO, DISPNEIA, HUMOR ALTERADO, GENGIVITE, HIRSUTISMO, ONICÓLISE, CASPA, DERMATITE, CRESCIMENTO ANORMAL DE PELOS, REAÇÃO DE FOTOSSENSIBILIDADE, DISTÚRBIO DE PIGMENTAÇÃO, DOR NOS OSSOS, ESPASMOS MUSCULARES, DOR NA EXTREMIDADE, PESO NAS EXTREMIDADES, VULVOVAGINITE ATRÓFICA, MASSA MAMÁRIA, DOEN ÇA FIBROCÍSTICA DA MAMA, ENDURECIMENTO DA MAMA. INTERAÇÕES MEDICAMENTOSAS: INDUTORES OU INIBIDORES ENZIMÁTICOS INDIVIDUAIS (CITOCROMO P450), SUBSTÂNCIAS COM PROPRIEDADES DE INDUÇÃO ENZIMÁTICA (FENITOÍNA, BARBITÚRICOS, PRIMIDONA, CARBAMAZEPINA, RIFAMPICINA E POSSIVELMENTE TAMBÉM OXCARBAZEPINA, TOPIRAMATO, FELBAMATO, GRISEOFULVINA, NEVIRAPINA E ERVA-DE-SÃO-JOÃO), SUBSTÂNCIAS COM PROPRIEDADES DE INIBIÇÃO ENZI MÁTICA (ANTIFÚNGICOS AZÓLICOS, CIMETIDINA, VERAPAMIL, MACROLÍDEOS, DILTIAZEM, INIBIDORES DA PROTEASE, ANTIDEPRESSIVOS E SUCO DE TORONJA). COM BASE EM ESTUDOS DE INIBIÇÃO IN VITRO, É IMPROVÁVEL QUE HAJA INTERAÇÃO CLINICAMENTE RELEVANTE ENTRE ALLURENE® E O METABOLISMO DE OUTROS MEDICAMENTOS MEDIADO PELA ENZIMA DO CITOCROMO P450. O USO DE PROGESTÓGENOS PODE INFLUENCIAR OS RESULTADOS DE CERTOS EXAMES LABORA TORIAIS, INCLUINDO PARÂMETROS BIOQUÍMICOS DO FÍGADO, TIREOIDE, FUNÇÃO RENAL E ADRENAL, NÍVEIS PLASMÁTICOS DE PROTEÍNAS (CARREADORAS), POR EXEMPLO, FRAÇÕES LIPOPROTEICAS/LIPÍDICAS, PARÂMETROS DO METABOLISMO DE CARBOIDRATOS E PARÂMETROS DA COAGULAÇÃO E FIBRINÓLISE. DE MODO GERAL, AS ALTERAÇÕES PERMANECEM DENTRO DA FAIXA LABORATORIAL NORMAL. POSOLOGIA: UM COMPRIMIDO POR DIA SEM INTERVALO DE PAUSA, TOMADO, PREFERENCIALMENTE, NO MESMO HORÁRIO TODOS OS DIAS, COM UM POUCO DE LÍQUIDO, SE NECESSÁRIO, INDEPENDENTEMENTE DE SANGRAMENTO VAGINAL. AO TÉRMINO DE UMA CARTELA, A PRÓXIMA DEVE SER INICIADA, SEM INTERRUPÇÃO. A INGESTÃO DOS COMPRIMIDOS PODE SER INICIADA EM QUALQUER DIA DO CICLO MENSTRUAL. VENDA SOB PRESCRIÇÃO MÉDICA.CONTRAINDICAÇÕES: DISTÚRBIOS CARDIOVASCULARES, DIABETES MELLITUS COM ENVOLVIMENTO VASCULAR. INTERAÇÕES MEDICAMENTOSAS: ANTICONVULSIVANTES, ANTIFÚNGICOS AZÓLICOS, ANTIDEPRESSIVOS. CONTRAINDICATIONS: CARDIOVASCULAR DISORDERS, DIABETES MELLITUS WITH VASCULAR DAMAGE. DRUG INTERACTIONS: ANTICONVULSANTS, AZOLE ANTIFUNGALS, ANTIDEPRESSANTS
G.WH.GT.03.2014.0053 L.BR.03.2014.1711
Breakfast Symposium
Ballroom7h00–8h00, Friday 02 May 2014
Innovation in endometriosis: perspectives from academia
& industry
Faculty: Charles Chapron (France), Oliver Martin Fischer, Bayer (Germany), Katy Vincent (UK), Thomas Zollner, Bayer (Germany)